<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">50175</article-id><article-id pub-id-type="doi">10.7554/eLife.50175</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Ligand recognition and gating mechanism through three ligand-binding sites of human TRPM2 channel</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-149988"><name><surname>Huang</surname><given-names>Yihe</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149989"><name><surname>Roth</surname><given-names>Becca</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-109111"><name><surname>Lü</surname><given-names>Wei</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3009-1025</contrib-id><email>wei.lu@vai.org</email><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-109301"><name><surname>Du</surname><given-names>Juan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1467-1203</contrib-id><email>juan.du@vai.org</email><xref ref-type="aff" rid="aff1"/><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>Van Andel Institute</institution><addr-line><named-content content-type="city">Grand Rapids</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Islas</surname><given-names>Leon D</given-names></name><role>Reviewing Editor</role><aff><institution>Universidad Nacional Autónoma de México</institution><country>Mexico</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Boudker</surname><given-names>Olga</given-names></name><role>Senior Editor</role><aff><institution>Weill Cornell Medicine</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>12</day><month>09</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>8</volume><elocation-id>e50175</elocation-id><history><date date-type="received" iso-8601-date="2019-07-12"><day>12</day><month>07</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-09-11"><day>11</day><month>09</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Huang et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Huang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-50175-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.50175.001</object-id><p>TRPM2 is critically involved in diverse physiological processes including core temperature sensing, apoptosis, and immune response. TRPM2’s activation by Ca<sup>2+</sup> and ADP ribose (ADPR), an NAD<sup>+</sup>-metabolite produced under oxidative stress and neurodegenerative conditions, suggests a role in neurological disorders. We provide a central concept between triple-site ligand binding and the channel gating of human TRPM2. We show consecutive structural rearrangements and channel activation of TRPM2 induced by binding of ADPR in two indispensable locations, and the binding of Ca<sup>2+</sup> in the transmembrane domain. The 8-Br-cADPR—an antagonist of cADPR—binds only to the MHR1/2 domain and inhibits TRPM2 by stabilizing the channel in an apo-like conformation. We conclude that MHR1/2 acts as a orthostatic ligand-binding site for TRPM2. The NUDT9-H domain binds to a second ADPR to assist channel activation in vertebrates, but not necessary in invertebrates. Our work provides insights into the gating mechanism of human TRPM2 and its pharmacology.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>ion channel</kwd><kwd>channel gating</kwd><kwd>ligand</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001207</institution-id><institution>Esther A. and Joseph Klingenstein Fund</institution></institution-wrap></funding-source><award-id>2019 class</award-id><principal-award-recipient><name><surname>Du</surname><given-names>Juan</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000872</institution-id><institution>McKnight Endowment Fund for Neuroscience</institution></institution-wrap></funding-source><award-id>2019 class</award-id><principal-award-recipient><name><surname>Du</surname><given-names>Juan</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01NS111031</award-id><principal-award-recipient><name><surname>Du</surname><given-names>Juan</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>High-resolution structures of human TRPM2 in different functional states provided the mechanism underlying ligand recognition, channel activation and inhibition.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>ADP ribose (ADPR) and its derivatives, which are products of NAD<sup>+</sup> metabolism, play essential roles in neurotoxicity and cellular signaling under many physiological and pathological conditions (<xref ref-type="bibr" rid="bib11">Ernst et al., 2013</xref>; <xref ref-type="bibr" rid="bib15">Gasser et al., 2006</xref>; <xref ref-type="bibr" rid="bib18">Guse, 2015</xref>; <xref ref-type="bibr" rid="bib30">Kolisek et al., 2005</xref>; <xref ref-type="bibr" rid="bib43">Nikiforov et al., 2015</xref>). In neurodegenerative diseases, the progressive accumulation of poly-ADPR and free ADPR results from poly(adenosine 5’-diphosphate-ribose) polymerase-1 activation, and contributes to neurotoxicity and neuronal death (<xref ref-type="bibr" rid="bib28">Kam et al., 2018</xref>). Intracellular ADPR targets and activates the nonselective, calcium-permeable TRPM2 channel in the presence of Ca<sup>2+</sup>. ADPR acts on one hand as a secondary messenger that contributes to insulin secretion, redox, and temperature sensation, but on the other hand, its accumulation results in intracellular calcium overload and eventually apoptosis (<xref ref-type="bibr" rid="bib20">Hara et al., 2002</xref>; <xref ref-type="bibr" rid="bib21">Hecquet et al., 2014</xref>; <xref ref-type="bibr" rid="bib52">Song et al., 2016</xref>; <xref ref-type="bibr" rid="bib55">Tan and McNaughton, 2016</xref>; <xref ref-type="bibr" rid="bib56">Togashi et al., 2006</xref>; <xref ref-type="bibr" rid="bib59">Uchida et al., 2011</xref>; <xref ref-type="bibr" rid="bib62">Wehage et al., 2002</xref>). TRPM2 is thus considered to be a key contributor in brain injury via a glutamate-independent pathway in neurodegenerative conditions or after stroke, and it has important functions in obesity, diabetes, bipolar disorder, and Alzheimer’s disease (<xref ref-type="bibr" rid="bib4">Aminzadeh et al., 2018</xref>; <xref ref-type="bibr" rid="bib26">Jang et al., 2015</xref>; <xref ref-type="bibr" rid="bib51">Sita et al., 2018</xref>; <xref ref-type="bibr" rid="bib60">Uchida and Tominaga, 2014</xref>; <xref ref-type="bibr" rid="bib70">Zhang et al., 2012</xref>).</p><p>Belonging to the transient receptor potential melastatin family (TRPM), TRPM2 shares a characteristic MHR1-4 domain, a transmembrane domain (TMD), and a coiled-coil domain with the other family members. It is unique due to owning a characteristic C-terminal NUDT9-H domain, which has been considered a classic binding site for ADPR and its derivatives (<xref ref-type="bibr" rid="bib12">Fliegert et al., 2017</xref>; <xref ref-type="bibr" rid="bib44">Perraud et al., 2001</xref>), but the presence of the ADPR binding site has not been directly observed. Recently, our group defined a novel ADPR binding site in the MHR1/2 domain that is essential for the activation of the zebrafish TRPM2 (<italic>dr</italic>TRPM2) channel (<xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>). It remains unclear whether the MHR1/2 domain is a universal binding site across all species; whether the NUDT9-H domain has a second ADPR binding site; and what the functional role of the NUDT9-H domain is. Beyond the agonist ADPR, TRPM2 also responds to a variety of ADPR orthologues including the agonist cyclic ADPR (cADPR) (<xref ref-type="bibr" rid="bib30">Kolisek et al., 2005</xref>; <xref ref-type="bibr" rid="bib69">Yu et al., 2019</xref>), which is produced during acute kidney injury (<xref ref-type="bibr" rid="bib30">Kolisek et al., 2005</xref>; <xref ref-type="bibr" rid="bib56">Togashi et al., 2006</xref>), and the antagonist 8-bromo-cyclic ADP-ribose (8-Br-cADPR), which decreases ischemia-reperfusion injury when used in treatment (<xref ref-type="bibr" rid="bib10">Eraslan et al., 2019</xref>). Interestingly, 8-Br-cADPR is an antagonist for cADPR but does not inhibit ADPR-evoked currents (<xref ref-type="bibr" rid="bib30">Kolisek et al., 2005</xref>). Despite extensive studies (<xref ref-type="bibr" rid="bib6">Baszczyňski et al., 2019</xref>; <xref ref-type="bibr" rid="bib10">Eraslan et al., 2019</xref>; <xref ref-type="bibr" rid="bib13">Fliegert et al., 2018</xref>; <xref ref-type="bibr" rid="bib14">Fourgeaud et al., 2019</xref>; <xref ref-type="bibr" rid="bib30">Kolisek et al., 2005</xref>; <xref ref-type="bibr" rid="bib32">Kühn et al., 2019</xref>; <xref ref-type="bibr" rid="bib41">Moreau et al., 2013</xref>; <xref ref-type="bibr" rid="bib58">Tóth and Csanády, 2010</xref>), there is limited knowledge about the TRPM2 drug binding sites and how drugs manipulate channel function.</p><p>Human TRPM2 (<italic>hs</italic>TRPM2) has several functional properties different from those of <italic>dr</italic>TRPM2 and invertebrate TRPM2, including temperature sensitivity and desensitization rate (<xref ref-type="bibr" rid="bib42">Nam Tran et al., 2018</xref>; <xref ref-type="bibr" rid="bib25">Iordanov et al., 2019</xref>). A recent publication suggested that <italic>hs</italic>TRPM2 does not bind ADPR in the MHR1/2 domain and that its activation is rather driven by ADPR binding in the NUDT9-H domain (<xref ref-type="bibr" rid="bib61">Wang et al., 2018</xref>). However, this suggestion was based on a cryo-electron microscopy (cryo-EM) structure of <italic>hs</italic>TRPM2 in the presence of ADPR and Ca<sup>2+</sup> at 6.4 Å, a resolution that cannot clarify whether ADPR is present in either the MHR1/2 or the NUDT9-H domain. Moreover, the assignment of the functional states of the structures in this paper is not clear because there is a lack of side-chain densities in the ADPR/Ca<sup>2+</sup>-bound structure and because the transmembrane domain (TMD) in the apo structure is barely visible.</p><p>To understand the mechanism underlying agonist and antagonist recognition, and gating mechanism of human TRPM2, we used single-particle cryo-EM to determine four full-length <italic>hs</italic>TRPM2 structures: in the apo state in the presence of EDTA (EDTA-<italic>hs</italic>TRPM2); in a non-activated state in complex with the agonist ADPR (ADPR-<italic>hs</italic>TRPM2); in a pre-open or an inactive state in the presence of ADPR/Ca<sup>2+</sup> (ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2); and in an inhibited state with the cADPR antagonist 8-Br-cADPR in the presence of Ca<sup>2+</sup> (8-Br-cADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2), at 3.3, 4.4, 3.7, and 3.7 Å, respectively (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplements 1</xref> and <xref ref-type="fig" rid="fig1s2">2</xref>).</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Structure determination of <italic>hs</italic>TRPM2</title><p>In our four <italic>hs</italic>TRPM2 structures, the densities for nearly the entire intracellular domain are well-defined, including the NUDT9-H domain and the β1-β2 loop of the MHR1 domain (<xref ref-type="fig" rid="fig1">Figure 1a–d</xref>, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>), which were poorly defined or unresolved in the <italic>dr</italic>TRPM2 structures (<xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>). In both ADPR-bound structures, ADPR densities were observed in two different sites on each subunit, one (ADPR1) in the cleft of the MHR1/2 domain and a second (ADPR2) in the cleft of the NUDT9-H domain (<xref ref-type="fig" rid="fig1">Figure 1b,c,f,g</xref>; <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>). In contrast, we found a ring-shaped 8-Br-cADPR density only in the cleft of the MHR1/2 domain of the 8-Br-cADRP/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 structure (<xref ref-type="fig" rid="fig1">Figure 1d,h</xref>; <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>). In addition, Ca<sup>2+</sup> density was visible in the ADPR/Ca<sup>2+</sup>- and 8-Br-cADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 maps (<xref ref-type="fig" rid="fig1">Figure 1g,h</xref>), in the same location as in the <italic>hs</italic>TRPM4, <italic>Ficedula albicollis </italic>TRPM8 (<italic>fa</italic>TRPM8), <italic>dr</italic>TRPM2, and <italic>Nematostella vectensis</italic> TRPM2 (<italic>nv</italic>TRPM2) structures (<xref ref-type="bibr" rid="bib5">Autzen et al., 2018</xref>; <xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>; <xref ref-type="bibr" rid="bib66">Yin et al., 2019a</xref>; <xref ref-type="bibr" rid="bib72">Zhang et al., 2018</xref>).</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.50175.002</object-id><label>Figure 1.</label><caption><title>The overall architecture of <italic>hs</italic>TRPM2.</title><p>The three-dimensional reconstructions of (<bold>a</bold>) EDTA-<italic>hs</italic>TRPM2, (<bold>b</bold>) ADPR-<italic>hs</italic>TRPM2, (<bold>c</bold>) ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2, and (<bold>d</bold>) 8-Br-cADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2. The unsharpened reconstructions are shown as transparent envelopes. One subunit is highlighted. (<bold>e–h</bold>) Atomic models of the corresponding reconstructions in panels a-d. The NUDT9-H domains are shown in solid surface, the MHR1/2 domains are shown in transparent surface, and the rest of the proteins are shown in cartoon representation. Ca<sup>2+</sup>, ADPR1, ADPR2, and 8-Br-cADPR are shown in purple, green, blue, and orange spheres, respectively. The center-of-mass (COM) of the MHR1/2 domain of one subunit in each structure is shown as a circle filled with white. The dimensions of the proteins and the difference between COMs along the pore axis are labeled.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50175-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.50175.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title>The cryo-EM data processing flowchart for <italic>hs</italic>TRPM2 using the data of ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 as an example.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50175-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.50175.004</object-id><label>Figure 1—figure supplement 2.</label><caption><title>Cryo-EM data analysis of <italic>hs</italic>TRPM2.</title><p>Representative electron micrograph; 2D class averages; the gold-standard Fourier shell correlation (FSC) curves for the electron microscopy map; the FSC curves between the atomic model and the final electron microscopy map; and angular distribution of refined particles for EDTA-<italic>hs</italic>TRPM2 (<bold>a–d</bold>), ADPR-<italic>hs</italic>TRPM2 (<bold>e–h</bold>), ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (<bold>i–l</bold>), and 8-Br-cADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (<bold>m–p</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50175-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.50175.005</object-id><label>Figure 1—figure supplement 3.</label><caption><title>Local resolution estimation and representative densities of <italic>hs</italic>TRPM2 structures.</title><p>(<bold>a–d</bold>) Local resolution estimation of EDTA-<italic>hs</italic>TRPM2 (<bold>a</bold>), ADPR-<italic>hs</italic>TRPM2 (<bold>b</bold>), ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (<bold>c</bold>), and 8-Br-cADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (<bold>d</bold>). The map is color-coded according to local resolution estimation. The unsharpened reconstructions are shown as transparent envelopes. (<bold>e–h</bold>) Representative densities of EDTA-<italic>hs</italic>TRPM2 (<bold>e</bold>), ADPR-<italic>hs</italic>TRPM2 (<bold>f</bold>), ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (<bold>g</bold>), and 8-Br-cADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (<bold>h</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50175-fig1-figsupp3-v2.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.50175.006</object-id><label>Figure 1—figure supplement 4.</label><caption><title>Ligand densities.</title><p>(<bold>a</bold>) The 2D chemical structures of ADPR and 8-Br-cADPR. (<bold>b</bold>) The densities for ADPR and 8-Br-cADPR in the full map, half map 1 and half map 2 of ADPR-<italic>hs</italic>TRPM2, ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 and 8-Br-cADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50175-fig1-figsupp4-v2.tif"/></fig><fig id="fig1s5" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.50175.007</object-id><label>Figure 1—figure supplement 5.</label><caption><title>Comparison of the structures of <italic>hs</italic>TPPM2, <italic>dr</italic>TRPM2, and <italic>nv</italic>TRPM2.</title><p>The atomic models of EDTA-<italic>hs</italic>TRPM2 (<bold>a</bold>), ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (<bold>b</bold>), EDTA-<italic>dr</italic>TRPM2 (<bold>c</bold>), ADPR/Ca<sup>2+</sup>-<italic>dr</italic>TRPM2 (<bold>d</bold>), and Ca<sup>2+</sup>-<italic>nv</italic>TRPM2 (<bold>e</bold>). The NUDT9-H domains are shown as a solid surface; the MHR1/2 domains are shown as transparent surfaces; and the rest of the proteins are shown in cartoon representation. The Ca<sup>2+</sup>, ADPR1, ADPR2, and 8-Br-cADPR are shown in purple, green, blue, and orange spheres, respectively. The center-of-mass (COM) of the MHR1/2 domain of one subunit in each structure is shown as a circle filled with white. The dimensions of the proteins, as well as the difference between COMs along pore axis are labeled. The invisible NUDT9-H domains in Ca<sup>2+</sup>-<italic>nv</italic>TRPM2 (<bold>e</bold>) are shown in cartoon representation with a dashed outline.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50175-fig1-figsupp5-v2.tif"/></fig></fig-group><p>While the majority of the TMD is also well-defined in the four <italic>hs</italic>TRPM2 structures (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3e–h</xref>), less well resolved are the extracellular half of the pore-lining helix S6, the pore helix/loop, and the extracellular loops, similar to those in the TRPM8 structures (<xref ref-type="bibr" rid="bib66">Yin et al., 2019a</xref>; <xref ref-type="bibr" rid="bib65">Yin et al., 2018</xref>). Nevertheless, we were able to trace the protein backbone in the S6 helix. We speculate that the poorly defined pore region is caused, at least partially, by β-mercaptoethanol, which is essential for stabilizing the protein during purification but may reduce the conserved disulfide bond formed by C996 and C1008 in the extracellular loops that is important for channel function (<xref ref-type="bibr" rid="bib27">Jang et al., 2019</xref>; <xref ref-type="bibr" rid="bib38">Mei et al., 2006</xref>; <xref ref-type="bibr" rid="bib40">Mittal et al., 2017</xref>; <xref ref-type="bibr" rid="bib39">Mittal et al., 2015</xref>). That bond is a key interaction that stabilizes the integrity of the pore region in the <italic>dr</italic>TRPM2 structure (<xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>).</p></sec><sec id="s2-2"><title>Overall architecture and structural comparison</title><p>The <italic>hs</italic>TRPM2 structures share a four-layer arrangement with <italic>dr</italic>TRPM2 (<xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>; <xref ref-type="bibr" rid="bib67">Yin et al., 2019b</xref>), having a TMD, MHR3/4, and a ligand-sensing layer that includes the MHR1/2 and NUDT9-H domains, from top to bottom. However, their overall shapes differ, primarily because the NUDT9-H domain is positioned differently. In the EDTA-<italic>hs</italic>TRPM2 structure (<xref ref-type="fig" rid="fig1">Figure 1e</xref>, <xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5a</xref>), the NUDT9-H domain is clamped between cognate and adjacent MHR1/2 domains, forming both intra- and intersubunit interfaces, while only the intrasubunit interface exists in the EDTA-<italic>dr</italic>TRPM2 structure (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5c</xref>). As a consequence, the NUDT9-H domain forms a compact structure interacting with the adjacent MHR1/2 domain in <italic>hs</italic>TRPM2, whereas it hangs freely in the <italic>dr</italic>TRPM2 on the bottom of the protein. Moreover, the NUDT9-H domain is completely invisible in the <italic>nv</italic>TRPM2 structure (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5e</xref>), despite high resolution of the rest of the protein (<xref ref-type="bibr" rid="bib72">Zhang et al., 2018</xref>). Such an incrementally tighter coupling between the NUDT9-H domain and the rest of the protein, from invertebrate TRPM2 to human TRPM2, is in line with previous reports that the NUDT9-H domain plays an important role in channel gating of <italic>hs</italic>TRPM2 and <italic>dr</italic>TRPM2, but does not affect the channel gating of <italic>nv</italic>TRPM2 (<xref ref-type="bibr" rid="bib12">Fliegert et al., 2017</xref>; <xref ref-type="bibr" rid="bib33">Kühn and Lückhoff, 2004</xref>; <xref ref-type="bibr" rid="bib62">Wehage et al., 2002</xref>; <xref ref-type="bibr" rid="bib68">Yu et al., 2017</xref>).</p><p>Relative to the apo state (<xref ref-type="fig" rid="fig1">Figure 1e</xref>), the binding of ADPR to <italic>hs</italic>TRPM2 yielded a markedly elevated MHR1/2 layer and a contracted NUDT9-H layer, with the NUDT9-H domain swinging toward the pore axis (<xref ref-type="fig" rid="fig1">Figure 1f–g</xref>). ADPR molecules were identified, with ADPR1 in the MHR1/2 domain and ADPR2 in the NUDT9-H domain (<xref ref-type="fig" rid="fig2">Figure 2a,c–f</xref>). Despite a long-existing consensus view that the NUDT9-H domain binds ADPR, this is the first time that the ADPR density has been visualized in this location (<xref ref-type="fig" rid="fig2">Figure 2d</xref>). In addition, the clearly defined ADPR1 in the MHR1/2 domain is consistent with the one observed in the <italic>dr</italic>TRPM2 structure (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5b,d</xref>) (<xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>). Given that key residues in the MHR1/2 site are conserved across species (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) and that the invertebrate <italic>nv</italic>TRPM2 responds to ADPR independent of their NUDT9-H domains (<xref ref-type="bibr" rid="bib31">Kühn et al., 2016</xref>), our data strongly supports the concept that that the ligand-binding site in MHR1/2 is conserved throughout all species.</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.50175.008</object-id><label>Figure 2.</label><caption><title>The ADPR1, ADPR2, and 8-Br-cADPR binding sites.</title><p>The structures of the ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (<bold>a</bold>) and 8-Br-cADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (<bold>b</bold>), with the locations of the ADPR1, ADPR2, and 8-Br-cADPR binding sites boxed. (<bold>c–d</bold>) Shapes of the ADPR1 (<bold>c</bold>) and ADPR2 (<bold>d</bold>) binding sites (outlined by red dashes). ADPR1 and ADPR2 are shown as sticks. (<bold>e–g</bold>) The ligand binding sites for ADPR1 (<bold>e</bold>), ADPR2 (<bold>f</bold>), and 8-Br-cADPR (<bold>g</bold>). The ligands, and key residues involved in ligand binding are shown as sticks. Superimposition of the human TRPM2 (protein in red and ADPR in green) with the zebrafish TRPM2 (white) shows that the ADPR1 sites are conserved in both organisms (<bold>e</bold>). Superimposition of the EDTA-<italic>hs</italic>TRPM2 with 8-Br-cADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 shows that binding of 8-Br-cADPR barely induces conformational change of the ADPR1 binding site. The bromine atom is shown as transparent sphere.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50175-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.50175.009</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Secondary structure arrangement of <italic>hs</italic>TRPM2 and sequence alignment of TRPM2 from selected species.</title><p>The TRPM2 sequences are from <italic>Homo sapiens</italic> (<italic>hs</italic>TRPM2), <italic>Gallus gallus</italic> (<italic>gg</italic>TRPM2), <italic>Branchiostoma floridae</italic> (<italic>bf</italic>TRPM2), <italic>Danio rerio</italic> (<italic>dr</italic>TRPM2), <italic>Nematostella vectensis</italic> (<italic>nv</italic>TRPM2), and <italic>Salpingoeca rosetta</italic> (<italic>sr</italic>TRPM2). The secondary structure prediction for <italic>hs</italic>TRPM2 was made using the JPred online server (<xref ref-type="bibr" rid="bib8">Drozdetskiy et al., 2015</xref>). The sequences were aligned using Clustal Omega (<xref ref-type="bibr" rid="bib50">Sievers et al., 2011</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50175-fig2-figsupp1-v2.tif"/></fig></fig-group><p>In contrast to ADPR binding, the binding of 8-Br-cADPR did not produce obvious changes in the overall shape of the protein relative to the apo state, in agreement with the view that a competitive antagonist inhibits the protein by stabilizing it in an apo-like state (<xref ref-type="fig" rid="fig1">Figure 1a,d,e,h</xref>; <xref ref-type="fig" rid="fig2">Figure 2b,g</xref>). Similar mechanism has been observed for human P2 × 3 receptor, in which the competitive antagonists TNP-ATP and A-317491 stabilize the apo/resting state (<xref ref-type="bibr" rid="bib35">Mansoor et al., 2016</xref>). Surprisingly, in our 8-Br-cADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 structure, the 8-Br-cADPR molecule is observed only in the cleft of MHR1/2 domain (<xref ref-type="fig" rid="fig2">Figure 2b</xref>), but not in the NUDT9-H domain as previously proposed (<xref ref-type="bibr" rid="bib10">Eraslan et al., 2019</xref>; <xref ref-type="bibr" rid="bib30">Kolisek et al., 2005</xref>). This observation further supports the idea that the MHR1/2 domain is a key ligand-binding site not only for the agonist ADPR but also for the antagonist 8-Br-cADPR of cADPR.</p></sec><sec id="s2-3"><title>Ligand-binding sites</title><p>The presence of both ADPR and Ca<sup>2+</sup> initiates a rapid opening of <italic>hs</italic>TRPM2, which permits the flow of cations through the ion-conducting pore (<xref ref-type="bibr" rid="bib7">Csanády and Törocsik, 2009</xref>; <xref ref-type="bibr" rid="bib37">McHugh et al., 2003</xref>; <xref ref-type="bibr" rid="bib44">Perraud et al., 2001</xref>; <xref ref-type="bibr" rid="bib53">Starkus et al., 2007</xref>). Contrary to the consensus view that the NUDT9-H domain is the only binding site for ADPR and its derivatives, we found that the MHR1/2 domain binds both ADPR and 8-Br-cADPR, whereas NUDT9-H is only accessible to ADPR. Although both sites bind ADPR, the shapes of the two binding sites are distinct, which means that access is limited to ligands of a certain molecular geometry (<xref ref-type="fig" rid="fig2">Figure 2a,c,d</xref>).</p><p>The binding site in the bi-lobed MHR1/2 cleft is relatively deep, small, and circular. Therefore, ADPR1 is bent into a compact U shape to adapt to the MHR1/2 site (<xref ref-type="fig" rid="fig2">Figure 2c</xref>), similar to the finding in the <italic>dr</italic>TRPM2 structure (<xref ref-type="fig" rid="fig2">Figure 2e</xref>) (<xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>). ADPR1 is clamped between Y295 and the loop connecting the β5 strand α3 helix (β5-α3 loop), with the terminal adenine and terminal ribose moieties close to each other (<xref ref-type="fig" rid="fig2">Figure 2e</xref>). Two phosphate groups interact with R358 and the N-terminus of the α7 helix, while the ribose moiety of the adenosine group coordinates with R302.</p><p>In contrast, the cleft in the NUDT9-H domain is wider, embraced by its cap and core regions on each side and the central β sheet on the bottom, allowing ADPR2 to nestle in an extended shape with the terminal adenine and terminal ribose moieties far apart (<xref ref-type="fig" rid="fig2">Figure 2d</xref>). The adenine moiety of ADPR2 stacks between Y1485 and D1431, while the α-phosphate group interacts with R1433 (<xref ref-type="fig" rid="fig2">Figure 2f</xref>). The β-phosphate group and the terminal ribose group are less well defined, presumably due to lack of interaction with the protein. ADPR2 in such an extended shape has been observed in other high-resolution structures such as the human protein ADP-ribosylargenine hydrolase (<xref ref-type="bibr" rid="bib47">Rack et al., 2018</xref>).</p><p>The 8-Br-cADPR shares a similar shape with the U-shaped ADPR1 by connecting the terminal adenine and terminal ribose moieties, but it differs from the extended shape of ADPR2, thus fitting only into the MHR1/2 site (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). While the residues interacting with 8-Br-cADPR, including Y295 and residues in the β5-α3 loop, are mostly the same as those interacting with ADPR1, a small displacement of the side chain of Y295 was observed due to the extra bromine atom of 8-Br-cADPR (<xref ref-type="fig" rid="fig2">Figure 2g</xref>).</p><p>To ground of our interpretations of the dual ADPR binding sites in the ligand-sensing domain of TRPM2 in the context of physiological function, we generated mutants of key residues involved in ADPR binding on both sites and we conducted inside-out patch-clamp experiments. Based on several lines of evidence, we concluded that MHR1/2 represents an orthosteric binding site in TRPM2 across all species. First, several mutants of the key residues in the binding site in the MHR1/2 domain either markedly decreased or abolished channel activation in response to ADPR/Ca<sup>2+</sup>, which is caused by either altered affinity of ADPR to the MHR1/2 site, or altered allosteric transition from ligand binding to channel opening, or a combination of both (<xref ref-type="fig" rid="fig3">Figure 3a–c</xref>). These results indicate that the MHR1/2 binding site is crucial for channel gating of <italic>hs</italic>TRPM2, which agrees with previous functional studies on <italic>hs</italic>TRPM2 and <italic>dr</italic>TRPM2 (<xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>; <xref ref-type="bibr" rid="bib29">Kashio et al., 2012</xref>; <xref ref-type="bibr" rid="bib34">Luo et al., 2018</xref>). Second, key residues responsible for ligand binding in the MHR1/2 site are highly conserved across species from invertebrates to mammals, whereas those in the NUDT9-H site are less conserved (<xref ref-type="fig" rid="fig3">Figure 3d</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Third, ADPR-evoked channel activation of invertebrate <italic>nv</italic>TRPM2 is independent of its NUDT9-H domain, because truncation of that domain does not affect channel function (<xref ref-type="bibr" rid="bib25">Iordanov et al., 2019</xref>; <xref ref-type="bibr" rid="bib31">Kühn et al., 2016</xref>).</p><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.50175.010</object-id><label>Figure 3.</label><caption><title>Residues and domain that are critical for ADPR-invoked channel activation.</title><p>(<bold>a</bold>) Statistics of current amplitudes and cell numbers of inside-out patches pulled from HEK293 cells transfected with wild-type <italic>hs</italic>TPRM2, alanine mutants of key residues in the ADPR1 and ADPR2 sites, and a NUDT9-H-truncated construct, ∆NUDT9-H. Control experiments were carried out using non-transfected HEK293 cells. Mutants showing significantly smaller currents than the wild-type <italic>hs</italic>TRPM2 are labeled with asterisks (****: <italic>p</italic>&lt;0.0001). Data represent the mean ± s. e. m. and numbers on the top of each column indicated the number of patches that recorded. Values from individual experiments are shown as filled circles. (<bold>b</bold>) Representative current in an inside-out patch pulled from HEK293 cell transfected with wild-type <italic>hs</italic>TRPM2 cDNA. (<bold>c</bold>) Surface expression profiles of <italic>hs</italic>TRPM2 constructs used in (<bold>b</bold>), detected by in-gel GFP fluorescence. Most of the mutants showed expression comparable to that of the wild-type <italic>hs</italic>TRPM2; the ∆NUDT9-H showed weaker but recognizable expression at lower molecular weight due to truncation of the NUDT9-H domain. (<bold>d</bold>) Sequence alignment of the ADPR1 and ADPR2 binding sites (<italic>hs</italic> = <italic>Homo sapiens; dr</italic> = <italic>Danio rerio; nv</italic> = <italic>Nematostella vectensis</italic>). Key residues for ligand binding are in bold.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50175-fig3-v2.tif"/></fig><p>The next question is whether the NUDT9-H site acts as an allosteric binding site or as a second orthosteric binding site. Our electrophysiology data (<xref ref-type="fig" rid="fig3">Figure 3a</xref>), as well as previous reports by other labs (<xref ref-type="bibr" rid="bib12">Fliegert et al., 2017</xref>; <xref ref-type="bibr" rid="bib68">Yu et al., 2017</xref>), showed that mutations of the key residues in the NUDT9-H site markedly affected the channel function of <italic>hs</italic>TRPM2, indicating that this binding site is indispensable for <italic>hs</italic>TRPM2 activation. We suggest that the binding of ADPR to the NUDT9-H site assists channel opening in <italic>hs</italic>TRPM2, which will be discussed in the next section.</p></sec><sec id="s2-4"><title>Principles of agonist and antagonist actions in channel gating</title><p>The coexistence of three ligand-binding sites—a Ca<sup>2+</sup> binding site in the TMD and two ADPR binding sites in the ligand-sensing layer consisting of the MHR1/2 and NUDT9-H domains—endows <italic>hs</italic>TRPM2 a complicated gating mechanism. The ADPR- and ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 structures differ only in the S1-S4 domain, suggesting that the conformational changes induced by Ca<sup>2+</sup> binding is restricted in the TMD and Ca<sup>2+</sup> binding facilitates the channel opening, which agrees with published structures of <italic>dr</italic>TRPM2 and <italic>hs</italic>TRPM4 (<xref ref-type="bibr" rid="bib5">Autzen et al., 2018</xref>; <xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>). Therefore, the intracellular domain is solely manipulated by the ligands binding in the MHR1/2 and NUDT9-H sites.</p><p>To understand their relationship with channel gating, we first compared the ligand-sensing layer of the three ligand-bound <italic>hs</italic>TRPM2 structures with the apo state structure. Despite a different relative positioning between the NUDT9-H and the MHR1/2 domains, the <italic>hs</italic>TRPM2 showed a rearrangement of the ligand-sensing layer upon binding of ADPR similar to that of <italic>dr</italic>TRPM2 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1a–c</xref>) (<xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>). These conserved movements include a pendulum swing of the NUDT9-H domain toward pore axis, along with a contraction and clockwise rotation of the entire NUDT9-H layer, and an upward shift and an outward rotation of the MHR1/2 domain. By contrast, binding of 8-Br-cADPR did not result in an obvious conformational change of these two domains (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1a,d</xref>).</p><p>To explore the actions of agonists and antagonists, we compared the MHR1/2 domain and the NUDT9-H domain of <italic>hs</italic>TRPM2 in the absence or presence of ligands. ADPR binding into the cleft of MHR1/2 led to a clamshell closure similar to that observed in the <italic>dr</italic>TRPM2 structures (<xref ref-type="fig" rid="fig4">Figure 4a</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1e–f</xref>). Binding of ADPR into the cleft of the NUDT9-H induced a rigid-body rotation of the core region toward the cap region, resulting in a bi-lobed domain closure (<xref ref-type="fig" rid="fig4">Figure 4b</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1h–i</xref>). This is the first time that such a motion upon ligand binding has been observed for the NUDT9-H domain, which is likely conserved in its analog – the mitochondrial ADP-ribose pyrophosphatase, NUDT9 (<xref ref-type="bibr" rid="bib49">Shen et al., 2003</xref>).</p><fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.50175.011</object-id><label>Figure 4.</label><caption><title>Domain rearrangement of the ligand-sensing layer – the MHR1/2 and NUDT9-H domains – upon binding of ADPR or 8-Br-cADPR.</title><p>Comparison of (<bold>a</bold>) the MHR1/2 domains and (<bold>b</bold>) the NUDT9-H domains of EDTA-<italic>hs</italic>TRPM2 (blue) and ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (red) by superimposition of the MHR1 domains or the cap regions. Domain closure was observed in the MHR1/2 and NUDT9-H domains upon ADPR binding. (<bold>c</bold>) In the apo resting state, the intersubunit interface (resting interface) is formed by the MHR1 domain and the adjacent core region of the NUDT9-H domain. The rectangle is enlarged in the lower image. (<bold>d</bold>) Upon binding of ADPR, the intersubmit interface (activation interface) is reorganized and is formed by the MHR2 domain and the adjacent core region. The two adjacent subunits are colored in dark or light colors. Key elements involved in intersubunit interfaces are labeled. (<bold>e</bold>) Binding of 8-Br-cADPR to the MHR1/2 domain does not result in domain rearrangement of the ligand-sensing layer relative to the apo state shown in panel c.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50175-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.50175.012</object-id><label>Figure 4—figure supplement 1.</label><caption><title>Conformational rearrangements in the ligand-sensing layer of <italic>hs</italic>TRPM2 upon binding of ligands.</title><p>(<bold>a–d</bold>) Conformational changes of NUDT9-H domain and MHR1/2 domain upon ADPR or 8-Br-cADPR binding for EDTA-<italic>hs</italic>TRPM2 (a, blue), ADPR-<italic>hs</italic>TRPM2 (b, yellow), ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (c, red), and 8-Br-cADPR-<italic>hs</italic>TRPM2/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (d, green). The lower rotations are viewed from the intracellular side. The distances between the center of mass of the NUDT9-H domain and the MHR1/2 domain, and the angles between the center of mass of the NUDT9-H domain and the CTD coiled-coil pole along the pore axis, were measured and are indicated. (<bold>e–g</bold>) Comparisons of the MHR1/2 domain by superimposition of the MHR1 domains; colors show the structures from panels a-d that are being compared. ADPR1 binding produces an obvious MHR1/2 domain closure (<bold>e, f</bold>), and 8-Br-cADPR stabilizes MHR1/2 in an apo-like conformation (<bold>g</bold>). (<bold>h–j</bold>) Comparison of the NUDT9-H domain by superimposition of the cap regions, showing that ADPR2 binding produces noticeable domain closure; colors as for panels (<bold>e-g</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50175-fig4-figsupp1-v2.tif"/></fig></fig-group><p>In contrast, the binding of 8-Br-cADPR barely produced any conformational changes (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1g,j</xref>). Despite the fact that 8-Br-cADPR mimics U-shaped ADPR, the extra bromide atom is obstructed by Y295 (<xref ref-type="fig" rid="fig2">Figure 2g</xref>), preventing 8-Br-cADPR from going as deep as ADPR into the MHR1/2 cleft. As a result, the phosphate groups of 8-Br-cADPR block helix α7 from approaching, thus precluding clamshell closure (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1g</xref>). This supports the concept that 8-Br-cADPR acts as an antagonist for cADPR in <italic>hs</italic>TRPM2, which inhibits the channel by occupying and keeping the MHR1/2 clamshell in an open conformation and stabilizing <italic>hs</italic>TRPM2 in an apo/resting-like state. Such action of an antagonist has been reported for other ion channels (<xref ref-type="bibr" rid="bib35">Mansoor et al., 2016</xref>).</p><p>On the basis of structural comparison among the <italic>hs</italic>TPRM2 structures and the previously published functional studies on invertebrate TRPM2 (<xref ref-type="bibr" rid="bib25">Iordanov et al., 2019</xref>; <xref ref-type="bibr" rid="bib31">Kühn et al., 2016</xref>), we suggest that the MHR1/2 clamshell closure is the major driving force of channel opening by initiating motion in the intracellular domain which is transduced to the TMD, eventually causing channel opening in cooperation with Ca<sup>2+</sup>. This raises a key question of why it is necessary to have a second ADPR molecule binding in NUDT9-H for channel activation.</p><p>To address this question, we inspected into the ligand-sensing domain upon binding of ADPR and found a striking interface rearrangement between NUDT9-H and the adjacent MHR1/2 domain (<xref ref-type="fig" rid="fig4">Figure 4c–d</xref>). In the absence of ADPR, their interface is made of extensive interactions between the core region of NUDT9-H and MHR1 (<xref ref-type="fig" rid="fig4">Figure 4c</xref>). Upon binding of ADPR, their interface in the apo resting state is disrupted, and a new interface is created in the activation state between the core region and MHR2 (<xref ref-type="fig" rid="fig4">Figure 4d</xref>). Accordingly, we call the interface between MHR1/2 and NUDT9-H a resting interface in the apo state and an activation interface in the ADPR-bound state. Because the core region of the NUDT9-H domain rotates toward the cap region upon binding of ADPR2, we suggest that the ADPR2 may play a role in disrupting the resting interface by pulling the core region away from the adjacent MHR1 domain, which in turn promotes the clamshell closure of MHR1/2 upon binding of ADPR1—a motion that requires flexibility of NUDT9-H that moves along with MHR2, thus assisting channel activation. The binding of 8-Br-cADPR (<xref ref-type="fig" rid="fig4">Figure 4e</xref>) did not produce any domain rearrangement relative to the apo state (<xref ref-type="fig" rid="fig4">Figure 4c</xref>).</p></sec><sec id="s2-5"><title>Channel activation and inhibition</title><p>The conformational change of the ligand-sensing layer upon binding of ADPR is transduced to the TMD through MHR3/4, whose motion is conserved between <italic>hs</italic>TRPM2 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>) and <italic>dr</italic>TRPM2 (<xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>). To determine the functional states of the four <italic>hs</italic>TRPM2 structures, we looked at into their pore regions and compared their TMDs (<xref ref-type="fig" rid="fig5">Figure 5a–g</xref>). By comparing the distances between the Cα of adjacent pore-restricting residues—N1049 and Q1053—with those in <italic>dr</italic>TRPM2 (<xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>), all four showed an occluded pore, including the ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 structure (<xref ref-type="fig" rid="fig5">Figure 5c</xref>). The EDTA-<italic>hs</italic>TRPM2 and the 8-Br-cADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 structures (<xref ref-type="fig" rid="fig5">Figure 5a,d</xref>) were nearly identical, and they clearly represented an apo-resting state and an antagonist-bound inhibited closed state, respectively. In contrast, binding of ADPR caused large conformational changes throughout the protein relative to the apo state. Within the TMD specifically, although the pore domain showed little change, the S1-S4 domain underwent a remarkable clockwise rotation around the pore axis (<xref ref-type="fig" rid="fig5">Figure 5e,f</xref>). The subtle difference between the S1-S4 domains in ADPR- and ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 was caused by the binding of Ca<sup>2+</sup> (<xref ref-type="fig" rid="fig5">Figure 5g</xref>). The Ca<sup>2+</sup> is coordinated by E843, Q846, N869, D872 and E1073, which are conserved among all the Ca<sup>2+</sup>-sensitive TRPM channels (<xref ref-type="fig" rid="fig5">Figure 5h</xref>) (<xref ref-type="bibr" rid="bib5">Autzen et al., 2018</xref>; <xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>; <xref ref-type="bibr" rid="bib64">Yamaguchi et al., 2019</xref>; <xref ref-type="bibr" rid="bib66">Yin et al., 2019a</xref>). Because ADPR alone cannot active the TRPM2 channel in the absence of Ca<sup>2+</sup> (<xref ref-type="bibr" rid="bib37">McHugh et al., 2003</xref>; <xref ref-type="bibr" rid="bib54">Sumoza-Toledo and Penner, 2011</xref>), we designated the ADPR-<italic>hs</italic>TRPM2 structure as a ADPR-bound non-activated state.</p><fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.50175.013</object-id><label>Figure 5.</label><caption><title>The ion-conducting pore.</title><p>The gates of (<bold>a</bold>) EDTA-<italic>hs</italic>TRPM2, (<bold>b</bold>) ADPR-<italic>hs</italic>TRPM2, (<bold>c</bold>) ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2, and (<bold>d</bold>) 8-Br-cADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2, viewed from the intracellular side. The distances between the Cα atoms of adjacent N1049 and the distances between the Cα atoms of adjacent Q1053 are indicated. (<bold>e–g</bold>) Comparison of the TMDs of EDTA-<italic>hs</italic>TRPM2 and ADPR-<italic>hs</italic>TRPM2 (<bold>e</bold>), EDTA-<italic>hs</italic>TRPM2 and ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (<bold>f</bold>), and ADPR-<italic>hs</italic>TRPM2 and ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (<bold>g</bold>) by superimposition of their pore domain of the tetramer. While the pore-lining S6 and S5 are well aligned, a clockwise rotation of the S1-S4 domain and TRP helix is observed from EDTA-<italic>hs</italic>TRPM2 and ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2. (<bold>h</bold>) Calcium binding sites in the ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 structure. (<bold>i</bold>) The relative positioning between the S4-S5 linker and the TRP helix in ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2, viewed parallel to the membrane. The dashed arrow illustrates the proposed movement of the S4-S5 linker from one side to the other of the TRP helix, which is required for channel opening upon binding of ADPR/Ca<sup>2+</sup> that is observed in <italic>dr</italic>TRPM2 (<xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>). (<bold>j</bold>) Comparison of the S4-S5 linkers in ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (red) and ADPR/Ca<sup>2+</sup>-<italic>dr</italic>TRPM2 (black), viewed from the intracellular side. The two structures are superimposed using the TRP helix.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50175-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.50175.014</object-id><label>Figure 5—figure supplement 1.</label><caption><title>Conformational changes in the MHR3/4 domains upon binding of ADPR.</title><p>(<bold>a–b</bold>) The interfaces between the MHR3/4 domains and the transmembrane domain layer, and between the MHR3/4 domains and the MHR1/2 layer, in EDTA-<italic>hs</italic>TRPM2 (<bold>a</bold>) and ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (<bold>b</bold>). (<bold>c</bold>) Superimposition of the MHR3/4 domain layer of EDTA-<italic>hs</italic>TRPM2 and ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2, by aligning the CTD coiled-coil poles (residues 1144 to 1165), showing a counterclockwise upward rotation of MHR3/4 domain upon binding of ADPR and Ca<sup>2+</sup>. ADPR1 is shown as green spheres and ADPR2 is shown as blue spheres.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50175-fig5-figsupp1-v2.tif"/></fig></fig-group><p>The ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 structure is closed, unlike the ADPR/Ca<sup>2+</sup>-<italic>dr</italic>TRPM2 structure, which has a wide, open pore. A key element of the TRPM2 channel opening is the flipping of the S4-S5 linker from one side of the TRP helix to the other as a result of the synergetic actions of ADPR and Ca<sup>2+</sup>, which is derived from our two <italic>dr</italic>TRPM2 structures (<xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>). Indeed, the S4-S5 linkers in the ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 structure (<xref ref-type="fig" rid="fig5">Figure 5i,j</xref>) are un-flipped, indicating that the TMD conformation represents either a pre-open or an inactive state. We favor the former, because the structure of ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 is nearly identical with the non-activated ADPR-<italic>hs</italic>TRPM2. Moreover, the recently published two-fold symmetric <italic>dr</italic>TRPM2 adopts a hybrid of alternating non-flipped and flipped conformation of the S4-S5 linkers in TMD (<xref ref-type="bibr" rid="bib67">Yin et al., 2019b</xref>), the former of which represents an intermediate state after ligand binding but prior to channel opening, which is similar to the TMD conformation of in our ADPR/Ca<sup>2+</sup>-bound <italic>hs</italic>TRPM2 structure. This further supports that the ADPR/Ca<sup>2+</sup>-bound <italic>hs</italic>TRPM2 structure represents a pre-open state.</p><p>We have noted that the published <italic>hs</italic>TRPM2 structure in the presence of Ca<sup>2+</sup> and ADPR at 6.4 Å overall resolution was reported as an open state (<xref ref-type="bibr" rid="bib61">Wang et al., 2018</xref>). However, that interpretation is questionable, not only because most of the transmembrane domain was poorly defined in the cryo-EM map but also because the S4-S5 linker in the ADPR/Ca<sup>2+</sup>-bound structure was clearly on the same side as in the apo resting structure (<xref ref-type="bibr" rid="bib61">Wang et al., 2018</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>A central concept of the relationship between ligand binding and channel gating in TRPM2 arises on the basis of our <italic>hs</italic>TRPM2 and <italic>dr</italic>TRPM2 structures, in which the functional state of the channel correlated with the conformation of the MHR1/2 domain; that is, the channel is in a ligand-free, apo (resting) state or an antagonist-bound inhibited state when MHR1/2 is open, and the channel is in an agonist-bound active state when the MHR1/2 is closed (<xref ref-type="fig" rid="fig6">Figure 6</xref>). The channel opening also requires the binding of Ca<sup>2+</sup> in the TMD and a second ADPR molecule in the NUDT9-H domain. Unlike the consensus view of the NUDT9-H domain acting as the primary binding site for ADPR and its analogs, our data suggest that MHR1/2 represents an orthosteric binding site in TRPM2 across species, with key interaction residues conserved from invertebrates to mammals. TRPM2 is one example in which activation of the channel requires the synergetic binding of two ligands in three distinct sites.</p><fig-group><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.50175.015</object-id><label>Figure 6.</label><caption><title>Schematic of ligand-sensing of <italic>hs</italic>TRPM2.</title><p>(<bold>a–c</bold>) Conformational changes of <italic>hs</italic>TRPM2 among antagonist-bound (<bold>a</bold>), apo-resting (<bold>b</bold>), and agonist-bound (<bold>c</bold>) structures, focusing on the three ligand-binding sites. (<bold>a</bold>) 8-Br-cADPR binds only to the cleft of the MHR1/2 domain but not to the NUDT9-H domain. It inhibits the channel by stabilizing the MHR1/2 domain in an apo-like conformation. The Ca<sup>2+</sup> binding causes a tilting of the nearby S3 in the TMD, which is suggested to facilitate channel opening in the presence of agonist ADPR (<xref ref-type="bibr" rid="bib7">Csanády and Törocsik, 2009</xref>; <xref ref-type="bibr" rid="bib37">McHugh et al., 2003</xref>; <xref ref-type="bibr" rid="bib53">Starkus et al., 2007</xref>). However, Ca<sup>2+</sup> alone is not sufficient to open the channel. (<bold>c</bold>) Conformational changes of <italic>hs</italic>TRPM2 upon binding of Ca<sup>2+</sup> and ADPR in triple binding sites with Ca<sup>2+</sup> bound nearby S3, the U-shaped ADPR1 (green) in the cleft of MHR1/2 domain, and the extended ADPR2 (blue) in the cleft of NUDT9-H domain. Binding of ADPR1 and ADPR2 induces bi-lobed domain closure of the MHR1/2 domain and the NUDT9-H domain, respectively. The MHR1/2 domain shows a counterclockwise rotation and the NUDT9-H domain swings toward the pore center. As a result, the resting interface is disrupted, and an activation interface is created between adjacent subunits. The movements induced by ADPR in the MHR1/2 domain and NUDT9-H domain are shown by arrows.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50175-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.50175.016</object-id><label>Figure 6—figure supplement 1.</label><caption><title>Comparison of the NUDT9-H domain with the NUDT9 enzyme.</title><p>(<bold>a–b</bold>) Superimposition of NUDT9 enzyme (PDB: 1QVJ, cyan) and NUDT9-H domain in EDTA-<italic>hs</italic>TRPM2 (a, blue) and ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 (b, red) by aligning the cap regions. The ribose-5-phosphate (R5P) in the NUDT9 is shown as cyan spheres and the ADPR2 in the ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 is shown as blue spheres.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50175-fig6-figsupp1-v2.tif"/></fig></fig-group><p>What then is the function of the characteristic NUDT9-H domain? It is indispensable for vertebrate TRPM2 channel activation, including human and zebrafish, but it is not required in invertebrates <italic>nv</italic>TRPM2 (<xref ref-type="bibr" rid="bib31">Kühn et al., 2016</xref>). Comparison among the available TRPM2 structures reveals different interactions between NUDT9-H and MHR1/2 in human versus invertebrate TRPM2, which seemingly correlates with the functional importance of the NUDT9-H domain. In the <italic>nv</italic>TRPM2, the NUDT9-H domain likely lacks any interface with the rest of the protein, because it is completely invisible in the structure, despite the rest of the protein being well resolved (<xref ref-type="bibr" rid="bib72">Zhang et al., 2018</xref>). By contrast, the <italic>dr</italic>TRPM2 has a visible but poorly defined NUDT9-H domain with a single major interface between the cognate MHR1/2 and NUDT9-H domains (<xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>). Lastly, the <italic>hs</italic>TRPM2 has a well-defined NUDT9-H domain that has two major interfaces with the rest of protein, one with the cognate MHR1/2 and the other with the adjacent MHR1/2 domain. Such an incrementally tighter interaction between the NUDT9-H domain and the rest of protein is in harmony with the fact that the NUDT9-H domain gained more function along the evolution from invertebrates to mammals, such as temperature sensing, redox sensing, and channel gating, to endow TRPM2 with a polymodal nature. In parallel, the NUDT9-H domain has lost the ability to hydrolyze ADPR into AMP and ribose-5-phosphate, a function that exists only in invertebrate TRPM2 and NUDT9 (<xref ref-type="bibr" rid="bib24">Iordanov et al., 2016</xref>; <xref ref-type="bibr" rid="bib25">Iordanov et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Tóth et al., 2014</xref>). A comparison between NUDT9-H in <italic>hs</italic>TRPM2 and NUDT9 (<xref ref-type="bibr" rid="bib49">Shen et al., 2003</xref>) shows a wider opening of the cleft in NUDT9 (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), which is likely related to the fact that the core region in <italic>hs</italic>TRPM2 is restricted by the adjacent MHR1/2, whereas NUDT9 lacks such a restriction. Such a restriction for the NUDT9-H domain is also missing in invertebrate TRPM2 such as <italic>nv</italic>TRPM2, perhaps giving rise to a similar cleft opening as in NUDT9 and thus preserved enzymatic activity (<xref ref-type="bibr" rid="bib25">Iordanov et al., 2019</xref>; <xref ref-type="bibr" rid="bib31">Kühn et al., 2016</xref>).</p><p>In summary, our human TRPM2 structures defined two distinctive ADPR binding sites, one in the MHR1/2 domain and one in the NUDT9-H domain. These structures demonstrate how incorporation of three different ligand binding sites, including the Ca<sup>2+</sup> site in the TMD, regulates channel function. Our work provides a clear structural explanation for ligand recognition, pharmacology, and the gating mechanism of the polymodal TRPM2 channel.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Construct description, Expression and purification of full-length human TRPM2</title><p>The full-length human <italic>TRPM2</italic> gene (UniProtKB - O94759) was synthesized by Bio Basic and subcloned into a pEG BacMam vector with a twin-Strep tag, His<sub>8</sub> tag, enhanced green fluorescent protein (eGFP), and a thrombin cleavage site at the N terminus of the gene (<xref ref-type="bibr" rid="bib17">Goehring et al., 2014</xref>; <xref ref-type="bibr" rid="bib19">Haley et al., 2019</xref>). Plasmid DNA for the <italic>hs</italic>TRPM2 construct was transformed into DH5alpha competent cells, expanded into a large-scale bacterial culture, and isolated using EndoFree Plasmid kits (Qiagen). Purified plasmid DNA was mixed with PEI 25K (Polysciences) in a 3:1 ratio of PEI to DNA (w/w) and incubated at room temperature for 30 min. The PEI–DNA mixture was added to a suspension culture of HEK293 cells (ATCC Cat# CRL-11268, tested negative for mycoplasma contamination) at a density of 2.5–3.0 × 10<sup>6</sup>/mL for protein expression. After 12–24 hr post-transfection at 37°C, sodium butyrate (10 mM) was added to the suspension and the temperature was adjusted to 30°C to boost the protein expression. Seventy-two hours after transfection, HEK293 cells were harvested and washed with cold TBS buffer (150 mM NaCl, 20 mM Tris HCl, pH 8.0).</p><p>Harvested cells were lysed for 1 hr in 10 mM Tris-HCl pH 8.0 buffer containing a protease inhibitor cocktail (1 mM phenylmethylsulfonyl fluoride (PMSF), 2 mM pepstatin, 0.8 µM aprotinin, and 2 µg/ml leupeptin). After 1 hr of incubation, Tris-HCl pH 8.0 and NaCl were added to final concentrations of 20 mM and 150 mM, respectively. Lysed cells were incubated on ice for an additional 20 min. Cell debris and unlysed cells were removed by centrifugation at 2000 x <italic>g</italic> for 10 min. Ultracentrifugation was used to collect the membranes, using a 45 Ti rotor at 186,000 x <italic>g</italic> for 1 hr at 4°C (Beckman Coulter). The collected membranes were homogenized using a Dounce homogenizer in TBS buffer containing a protease inhibitor cocktail and 2 mM 2-mercaptoethanol. Solubilization of the membrane was performed by using 10 mM glyco-diosgenin (Anatrace) for 1 hr at 4°C before ultracentrifugation for 30 min at 186,000 x <italic>g</italic>. The supernatant was transferred out of centrifuge tubes and incubated with Talon resin (Clontech) for 2 hr. Talon resin was washed with six bed volumes of TBS buffer containing 0.2 mM glyco-diosgenin, 10 mM imidazole, and 2 mM 2-mercaptoethanol. The protein was eluted with TBS buffer containing 0.2 mM glyco-diosgenin, 250 mM imidazole, and 2 mM 2-mercaptoethanol. The protein eluate was collected, concentrated, and loaded onto a Superose 6 column (GE Healthcare) using TBS buffer containing 0.2 mM glyco-diosgenin and 5 mM 2-mercaptoethanol. The peak fractions were combined and concentrated to 6.0–7.0 mg/mL using a 100 kDa concentrator (Millipore).</p></sec><sec id="s4-2"><title>Electron microscopy sample preparation and data acquisition</title><p>Quantifoil holey carbon grids (Au 1.2/1.3 µm size/hole space, 300 mesh) were glow-discharged for 30 s before preparation. Purified and concentrated <italic>hs</italic>TRPM2 protein was incubated with either 1 mM EDTA; 1 mM ADPR (Sigma-Aldrich); 1 mM ADPR (Sigma-Aldrich) plus 1 mM CaCl<sub>2</sub>; or 1 mM 8-Br-cADPR (Santa Cruz Biotechnology) plus 1 mM CaCl<sub>2</sub>. After incubation, 2.5 µl of protein sample was added to the carbon face of the grids and blotted for 2 s with a 5 s waiting time. The grids were plunge-frozen into liquid ethane and then cooled by liquid nitrogen using a Vitrobot Mark III held at 18°C and 100% humidity.</p><p>Images were obtained using an FEI Titan Krios electron microscope operating at 300 kV with a nominal magnification of 130,000. Images were recorded by a Gatan K2 Summit direct electron detector, which operated in super-resolution counting mode and with a binned pixel size of 1.074 Å. Each image was dose-fractionated to 40 frames, with a total exposure time of 8 s and 0.2 s per frame. The dose rate was 6.76 e<sup>–</sup>Å<sup>–2</sup> s<sup>–1</sup> for each image. Images were recorded using an automated acquisition program (SerialEM) (<xref ref-type="bibr" rid="bib36">Mastronarde, 2005</xref>). Nominal defocus values varied between −1.3 to −1.9 µm.</p></sec><sec id="s4-3"><title>Electron microscopy data processing</title><p>Using MotionCor2 (<xref ref-type="bibr" rid="bib73">Zheng et al., 2017</xref>), images were motion-corrected, summed, and 2 × 2 binned in Fourier space. Defocus values were estimated using Gctf (<xref ref-type="bibr" rid="bib71">Zhang, 2016</xref>). Particles were then picked using Gautomatch (<ext-link ext-link-type="uri" xlink:href="http://www.mrc-lmb.cam.ac.uk/kzhang/Gautomatch/">http://www.mrc-lmb.cam.ac.uk/kzhang/Gautomatch/</ext-link>) and subjected to an initial reference-free 2D classification using RELION (<xref ref-type="bibr" rid="bib48">Scheres, 2012</xref>). Nine representative 2D class averages were selected to use as templates for automated particle-picking for the entire data set using Gautomatch. The auto-picked particles were then visually checked in order to remove false positives. Several rounds of 2D classification were performed to further clean up the selected particles using RELION (<xref ref-type="bibr" rid="bib48">Scheres, 2012</xref>). The initial reconstruction was obtained using cryoSPARC (<xref ref-type="bibr" rid="bib46">Punjani et al., 2017</xref>). The particles were then placed into ten classes using the 3D classification function in RELION (<xref ref-type="bibr" rid="bib48">Scheres, 2012</xref>), with the initial reconstruction low-pass-filtered to 50 Å as a reference model. Particles from classes showing high-resolution features were combined and refined with C4 symmetry using RELION (<xref ref-type="bibr" rid="bib48">Scheres, 2012</xref>) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). The final resolutions reported in <xref ref-type="table" rid="table1">Table 1</xref> are based on the gold standard Fourier shell correlation 0.143 criteria. A soft mask (6.4 Å extended from the reconstruction with an additional 6.4 Å cosine soft edge, low-pass-filtered to 15 Å) was applied to the two half maps in order to calculate the Fourier shell correlation plot. Local resolutions were estimated using Bsoft (<xref ref-type="bibr" rid="bib22">Heymann, 2018</xref>).</p><table-wrap id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.50175.017</object-id><label>Table 1.</label><caption><title>Statistics of 3D reconstruction and model refinement.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Data collection/processing</th><th valign="top">EDTA-<italic>hs</italic>TRPM2</th><th valign="top">ADPR-<italic>hs</italic>TRPM2</th><th valign="top">ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2</th><th valign="top">8-Br-cADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2</th></tr></thead><tbody><tr><td valign="top">Microscope</td><td valign="top">Titan Krios (FEI)</td><td valign="top">Titan Krios (FEI)</td><td valign="top">Titan Krios (FEI)</td><td valign="top">Titan Krios (FEI)</td></tr><tr><td valign="top">Voltage (kV)</td><td valign="top">300</td><td valign="top">300</td><td valign="top">300</td><td valign="top">300</td></tr><tr><td valign="top">Defocus range (µM)</td><td valign="top">1.0–2.5</td><td valign="top">1.0–2.5</td><td valign="top">1.0–2.5</td><td valign="top">1.0–2.5</td></tr><tr><td valign="top">Exposure time (s)</td><td valign="top">8</td><td valign="top">8</td><td valign="top">8</td><td valign="top">8</td></tr><tr><td valign="top">Dose rate (<italic>e</italic><sup>-</sup>/Å<sup>2</sup>/s)</td><td valign="top">6.8</td><td valign="top">6.8</td><td valign="top">6.8</td><td valign="top">6.8</td></tr><tr><td valign="top">Number of frames</td><td valign="top">40</td><td valign="top">40</td><td valign="top">40</td><td valign="top">40</td></tr><tr><td valign="top">Pixel size (Å)</td><td valign="top">1.076</td><td valign="top">1.076</td><td valign="top">1.076</td><td valign="top">1.076</td></tr><tr><td valign="top">Particles picked</td><td valign="top">783,885</td><td valign="top">537,671</td><td valign="top">2,342,060</td><td valign="top">1,822,211</td></tr><tr><td valign="top">Particles 2D</td><td valign="top">415,415</td><td valign="top">346,032</td><td valign="top">759,700</td><td valign="top">729,269</td></tr><tr><td valign="top">Particles refined</td><td valign="top">161,360</td><td valign="top">117,350</td><td valign="top">287,184</td><td valign="top">102,259</td></tr><tr><td valign="top">Resolution (Å)</td><td valign="top">3.3</td><td valign="top">4.4</td><td valign="top">3.7</td><td valign="top">3.7</td></tr><tr><td valign="top">FSC threshold</td><td valign="top">0.143</td><td valign="top">0.143</td><td valign="top">0.143</td><td valign="top">0.143</td></tr><tr><td valign="top">Resolution range (Å)</td><td valign="top">322.2–3.3</td><td valign="top">322.2–4.4</td><td valign="top">322.2–3.7</td><td valign="top">322.2–3.7</td></tr><tr><td valign="top"><bold>Model statistics</bold></td><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Number of atoms</td><td valign="top">37816</td><td valign="top">37308</td><td valign="top">37408</td><td valign="top">38492</td></tr><tr><td valign="top">Protein</td><td valign="top">37816</td><td valign="top">37020</td><td valign="top">37116</td><td valign="top">38344</td></tr><tr><td valign="top">Ligand</td><td valign="top">0</td><td valign="top">288</td><td valign="top">292</td><td valign="top">148</td></tr><tr><td valign="top">r.m.s. deviations</td><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Bond length (Å)</td><td valign="top">0.007</td><td valign="top">0.008</td><td valign="top">0.009</td><td valign="top">0.006</td></tr><tr><td valign="top">Bond angle (°)</td><td valign="top">0.907</td><td valign="top">1.015</td><td valign="top">1.051</td><td valign="top">0.941</td></tr><tr><td valign="top">Ramachandran plot</td><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Favored (%)</td><td valign="top">92.18</td><td valign="top">91.59</td><td valign="top">91.53</td><td valign="top">94.33</td></tr><tr><td valign="top">Allowed (%)</td><td valign="top">7.59</td><td valign="top">8.02</td><td valign="top">8.08</td><td valign="top">5.44</td></tr><tr><td valign="top">Disallowed (%)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td></tr><tr><td valign="top">Rotamer outlier (%)</td><td valign="top">0.35</td><td valign="top">1.40</td><td valign="top">1.38</td><td valign="top">1.13</td></tr></tbody></table></table-wrap></sec><sec id="s4-4"><title>Model building and structural determination</title><p>Models for human TRPM2 were built in Coot using the zebrafish TRPM2 structure as a reference (RCSB Protein Data Bank (PDB) ID: 6DRK and 6DRJ) (<xref ref-type="bibr" rid="bib23">Huang et al., 2018</xref>). The initial models were then subjected to real space refinement using phenix.real_space_refine (<xref ref-type="bibr" rid="bib2">Afonine et al., 2012</xref>) with secondary-structure restraints. The refined model was further manually examined and adjusted in Coot (<xref ref-type="bibr" rid="bib9">Emsley et al., 2010</xref>). For validation of the refined structure, Fourier shell correlation curves were applied to calculate the difference between the final model and electron microscopy map by PHENIX comprehensive validation (cryo-EM) (<xref ref-type="bibr" rid="bib3">Afonine et al., 2018</xref>). The geometries of the atomic models were evaluated using MolProbity (<xref ref-type="bibr" rid="bib63">Williams et al., 2018</xref>) in PHENIX suite (<xref ref-type="bibr" rid="bib1">Adams et al., 2010</xref>). All figures were prepared using UCSF Chimera (<xref ref-type="bibr" rid="bib45">Pettersen et al., 2004</xref>) and ChimeraX (<xref ref-type="bibr" rid="bib16">Goddard et al., 2018</xref>) and PyMOL (<ext-link ext-link-type="uri" xlink:href="https://pymol.org">https://pymol.org</ext-link>).</p></sec><sec id="s4-5"><title>Electrophysiology</title><p>HEK293 cells were transfected using Lipofectamine 2000 (Thermo Fisher) according to the manufacturer’s protocol. Transfected cells were plated in a 24-well plate and incubated at 37°C. The surface expression of WT human TRPM2 and mutants were evaluated by Pierce cell surface protein isolation kit (Thermo Fisher) according to the manufacturer’s protocol, except that the protein was eluted by TBS buffer supplemented with 50 mM Dithiothreitol (DTT) and detected by in-gel fluorescence. Currents from inside-out patches were recorded 12–24 hr post transfection and the recordings were performed by using a HEKA EPC-10 amplifier set to room temperature with a holding potential of +60 mV. The patch pipettes used for these experiments were filled with internal solution that consisted of 150 mM NaCl, 3 mM KCl, and 10 mM HEPES (pH 7.4, adjusted with NaOH). The bath solution was the same as the internal solution. A bath solution with 0.1 mM ADPR and 1 mM CaCl<sub>2</sub> was used to activate the <italic>hs</italic>TPRM2 channel expressed in HEK293 cells. To change the solution, a two-barrel theta-glass pipette controlled manually was used. Data was acquired at 10 kHz using Patchmaster software (HEKA) and for display purposes, data was digitally filtered at 100 Hz and down sampled by a factor of 10. Statistical analysis was done by GraphPad Prism (GraphPad Software), data was reported as mean ± s. e. m. and analyzed using an unpaired <italic>t</italic> - test.</p></sec><sec id="s4-6"><title>Data availability</title><p>The cryo-EM density map and coordinates of the <italic>hs</italic> TRPM2 apo state, the ADPR-bound state, the ADPR/Ca<sup>2+</sup>-bound state, and the 8-Br-cADPR/Ca<sup>2+</sup>-bound state have been deposited in the Electron Microscopy Data Bank (EMDB) under accession numbers EMD-20478, EMD-20479, EMD-20480 and EMD-20482 and in the Research Collaboratory for Structural Bioinformatics Protein Data Bank under accession codes 6PUO, 6PUR, 6PUS and 6PUU.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank G Zhao and X Meng for the support with data collection at the David Van Andel Advanced Cryo-Electron Microscopy Suite. We appreciate the HPC team in VARI for computational support. We thank W Sun (Janelia Research Campus) for his helpful discussion on electrophysiology experiments. We thank D Nadziejka for technical editing. JD is supported by a McKnight Scholar Award, a Klingenstein-Simon Scholar Award and the National Institutes of Health (NIH) (grant 1R01NS111031-01; JD).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Software, Formal analysis, Validation, Visualization, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Validation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.50175.018</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-50175-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All the cryo-EM data generated in this study have been deposited to PDB and EMDB databank.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Human TRPM2 in the apo state</data-title><source>Protein Data Bank</source><pub-id assigning-authority="PDB" pub-id-type="accession" xlink:href="http://www.rcsb.org/structure/6PUO">6PUO</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Human TRPM2 bound to ADPR and calcium</data-title><source>Protein Data Bank</source><pub-id assigning-authority="PDB" pub-id-type="accession" xlink:href="http://www.rcsb.org/structure/6PUS">6PUS</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Human TRPM2 bound to ADPR</data-title><source>Protein Data Bank</source><pub-id assigning-authority="PDB" pub-id-type="accession" xlink:href="http://www.rcsb.org/structure/6PUR">6PUR</pub-id></element-citation></p><p><element-citation id="dataset4" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Human TRPM2 bound to 8-Br-cADPR and calcium</data-title><source>Protein Data Bank</source><pub-id assigning-authority="PDB" pub-id-type="accession" xlink:href="http://www.rcsb.org/structure/6PUU">6PUU</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname> <given-names>PD</given-names></name><name><surname>Afonine</surname> <given-names>PV</given-names></name><name><surname>Bunkóczi</surname> <given-names>G</given-names></name><name><surname>Chen</surname> <given-names>VB</given-names></name><name><surname>Davis</surname> <given-names>IW</given-names></name><name><surname>Echols</surname> <given-names>N</given-names></name><name><surname>Headd</surname> <given-names>JJ</given-names></name><name><surname>Hung</surname> <given-names>LW</given-names></name><name><surname>Kapral</surname> <given-names>GJ</given-names></name><name><surname>Grosse-Kunstleve</surname> <given-names>RW</given-names></name><name><surname>McCoy</surname> <given-names>AJ</given-names></name><name><surname>Moriarty</surname> <given-names>NW</given-names></name><name><surname>Oeffner</surname> <given-names>R</given-names></name><name><surname>Read</surname> <given-names>RJ</given-names></name><name><surname>Richardson</surname> <given-names>DC</given-names></name><name><surname>Richardson</surname> <given-names>JS</given-names></name><name><surname>Terwilliger</surname> <given-names>TC</given-names></name><name><surname>Zwart</surname> <given-names>PH</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title><italic>PHENIX</italic>: a comprehensive Python-based system for macromolecular structure solution</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>66</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1107/S0907444909052925</pub-id><pub-id pub-id-type="pmid">20124702</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afonine</surname> <given-names>PV</given-names></name><name><surname>Grosse-Kunstleve</surname> <given-names>RW</given-names></name><name><surname>Echols</surname> <given-names>N</given-names></name><name><surname>Headd</surname> <given-names>JJ</given-names></name><name><surname>Moriarty</surname> <given-names>NW</given-names></name><name><surname>Mustyakimov</surname> <given-names>M</given-names></name><name><surname>Terwilliger</surname> <given-names>TC</given-names></name><name><surname>Urzhumtsev</surname> <given-names>A</given-names></name><name><surname>Zwart</surname> <given-names>PH</given-names></name><name><surname>Adams</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Towards automated crystallographic structure refinement with <italic>phenix.refine</italic></article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>68</volume><fpage>352</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1107/S0907444912001308</pub-id><pub-id pub-id-type="pmid">22505256</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afonine</surname> <given-names>PV</given-names></name><name><surname>Klaholz</surname> <given-names>BP</given-names></name><name><surname>Moriarty</surname> <given-names>NW</given-names></name><name><surname>Poon</surname> <given-names>BK</given-names></name><name><surname>Sobolev</surname> <given-names>OV</given-names></name><name><surname>Terwilliger</surname> <given-names>TC</given-names></name><name><surname>Adams</surname> <given-names>PD</given-names></name><name><surname>Urzhumtsev</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>New tools for the analysis and validation of cryo-EM maps and atomic models</article-title><source>Acta Crystallographica Section D Structural Biology</source><volume>74</volume><fpage>814</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1107/S2059798318009324</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aminzadeh</surname> <given-names>M</given-names></name><name><surname>Roghani</surname> <given-names>M</given-names></name><name><surname>Sarfallah</surname> <given-names>A</given-names></name><name><surname>Riazi</surname> <given-names>GH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>TRPM2 dependence of ROS-induced NLRP3 activation in Alzheimer's disease</article-title><source>International Immunopharmacology</source><volume>54</volume><fpage>78</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2017.10.024</pub-id><pub-id pub-id-type="pmid">29107864</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Autzen</surname> <given-names>HE</given-names></name><name><surname>Myasnikov</surname> <given-names>AG</given-names></name><name><surname>Campbell</surname> <given-names>MG</given-names></name><name><surname>Asarnow</surname> <given-names>D</given-names></name><name><surname>Julius</surname> <given-names>D</given-names></name><name><surname>Cheng</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structure of the human TRPM4 ion channel in a lipid nanodisc</article-title><source>Science</source><volume>359</volume><fpage>228</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1126/science.aar4510</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baszczyňski</surname> <given-names>O</given-names></name><name><surname>Watt</surname> <given-names>JM</given-names></name><name><surname>Rozewitz</surname> <given-names>MD</given-names></name><name><surname>Guse</surname> <given-names>AH</given-names></name><name><surname>Fliegert</surname> <given-names>R</given-names></name><name><surname>Potter</surname> <given-names>BVL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Synthesis of terminal ribose analogues of adenosine 5'-Diphosphate ribose as probes for the transient receptor potential cation channel TRPM2</article-title><source>The Journal of Organic Chemistry</source><volume>84</volume><fpage>6143</fpage><lpage>6157</lpage><pub-id pub-id-type="doi">10.1021/acs.joc.9b00338</pub-id><pub-id pub-id-type="pmid">30978018</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Csanády</surname> <given-names>L</given-names></name><name><surname>Törocsik</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Four Ca2+ ions activate TRPM2 channels by binding in deep crevices near the pore but intracellularly of the gate</article-title><source>The Journal of General Physiology</source><volume>133</volume><fpage>189</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1085/jgp.200810109</pub-id><pub-id pub-id-type="pmid">19171771</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drozdetskiy</surname> <given-names>A</given-names></name><name><surname>Cole</surname> <given-names>C</given-names></name><name><surname>Procter</surname> <given-names>J</given-names></name><name><surname>Barton</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>JPred4: a protein secondary structure prediction server</article-title><source>Nucleic Acids Research</source><volume>43</volume><fpage>W389</fpage><lpage>W394</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv332</pub-id><pub-id pub-id-type="pmid">25883141</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname> <given-names>P</given-names></name><name><surname>Lohkamp</surname> <given-names>B</given-names></name><name><surname>Scott</surname> <given-names>WG</given-names></name><name><surname>Cowtan</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Features and development of <italic>coot</italic></article-title><source>Acta Crystallographica. Section D, Biological Crystallography</source><volume>66</volume><fpage>486</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id><pub-id pub-id-type="pmid">20383002</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eraslan</surname> <given-names>E</given-names></name><name><surname>Tanyeli</surname> <given-names>A</given-names></name><name><surname>Polat</surname> <given-names>E</given-names></name><name><surname>Polat</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>8-Br-cADPR, a TRPM2 ion channel antagonist, inhibits renal ischemia-reperfusion injury</article-title><source>Journal of Cellular Physiology</source><volume>234</volume><fpage>4572</fpage><lpage>4581</lpage><pub-id pub-id-type="doi">10.1002/jcp.27236</pub-id><pub-id pub-id-type="pmid">30191993</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname> <given-names>IM</given-names></name><name><surname>Fliegert</surname> <given-names>R</given-names></name><name><surname>Guse</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Adenine dinucleotide second messengers and T-lymphocyte calcium signaling</article-title><source>Frontiers in Immunology</source><volume>4</volume><elocation-id>259</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2013.00259</pub-id><pub-id pub-id-type="pmid">24009611</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fliegert</surname> <given-names>R</given-names></name><name><surname>Watt</surname> <given-names>JM</given-names></name><name><surname>Schöbel</surname> <given-names>A</given-names></name><name><surname>Rozewitz</surname> <given-names>MD</given-names></name><name><surname>Moreau</surname> <given-names>C</given-names></name><name><surname>Kirchberger</surname> <given-names>T</given-names></name><name><surname>Thomas</surname> <given-names>MP</given-names></name><name><surname>Sick</surname> <given-names>W</given-names></name><name><surname>Araujo</surname> <given-names>AC</given-names></name><name><surname>Harneit</surname> <given-names>A</given-names></name><name><surname>Potter</surname> <given-names>BVL</given-names></name><name><surname>Guse</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ligand-induced activation of human TRPM2 requires the terminal ribose of ADPR and involves Arg1433 and Tyr1349</article-title><source>Biochemical Journal</source><volume>474</volume><fpage>2159</fpage><lpage>2175</lpage><pub-id pub-id-type="doi">10.1042/BCJ20170091</pub-id><pub-id pub-id-type="pmid">28515263</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fliegert</surname> <given-names>R</given-names></name><name><surname>Hölzer</surname> <given-names>HT</given-names></name><name><surname>Guse</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>TRPM2 activation: paradigm shifted?</article-title><source>Cell Calcium</source><volume>76</volume><fpage>132</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/j.ceca.2018.11.001</pub-id><pub-id pub-id-type="pmid">30420160</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fourgeaud</surname> <given-names>L</given-names></name><name><surname>Dvorak</surname> <given-names>C</given-names></name><name><surname>Faouzi</surname> <given-names>M</given-names></name><name><surname>Starkus</surname> <given-names>J</given-names></name><name><surname>Sahdeo</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>Q</given-names></name><name><surname>Lord</surname> <given-names>B</given-names></name><name><surname>Coate</surname> <given-names>H</given-names></name><name><surname>Taylor</surname> <given-names>N</given-names></name><name><surname>He</surname> <given-names>Y</given-names></name><name><surname>Qin</surname> <given-names>N</given-names></name><name><surname>Wickenden</surname> <given-names>A</given-names></name><name><surname>Carruthers</surname> <given-names>N</given-names></name><name><surname>Lovenberg</surname> <given-names>TW</given-names></name><name><surname>Penner</surname> <given-names>R</given-names></name><name><surname>Bhattacharya</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Pharmacology of JNJ-28583113: a novel TRPM2 antagonist</article-title><source>European Journal of Pharmacology</source><volume>853</volume><fpage>299</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2019.03.043</pub-id><pub-id pub-id-type="pmid">30965058</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasser</surname> <given-names>A</given-names></name><name><surname>Glassmeier</surname> <given-names>G</given-names></name><name><surname>Fliegert</surname> <given-names>R</given-names></name><name><surname>Langhorst</surname> <given-names>MF</given-names></name><name><surname>Meinke</surname> <given-names>S</given-names></name><name><surname>Hein</surname> <given-names>D</given-names></name><name><surname>Krüger</surname> <given-names>S</given-names></name><name><surname>Weber</surname> <given-names>K</given-names></name><name><surname>Heiner</surname> <given-names>I</given-names></name><name><surname>Oppenheimer</surname> <given-names>N</given-names></name><name><surname>Schwarz</surname> <given-names>JR</given-names></name><name><surname>Guse</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Activation of T cell calcium influx by the second messenger ADP-ribose</article-title><source>Journal of Biological Chemistry</source><volume>281</volume><fpage>2489</fpage><lpage>2496</lpage><pub-id pub-id-type="doi">10.1074/jbc.M506525200</pub-id><pub-id pub-id-type="pmid">16316998</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goddard</surname> <given-names>TD</given-names></name><name><surname>Huang</surname> <given-names>CC</given-names></name><name><surname>Meng</surname> <given-names>EC</given-names></name><name><surname>Pettersen</surname> <given-names>EF</given-names></name><name><surname>Couch</surname> <given-names>GS</given-names></name><name><surname>Morris</surname> <given-names>JH</given-names></name><name><surname>Ferrin</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>UCSF ChimeraX: meeting modern challenges in visualization and analysis</article-title><source>Protein Science</source><volume>27</volume><fpage>14</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1002/pro.3235</pub-id><pub-id pub-id-type="pmid">28710774</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goehring</surname> <given-names>A</given-names></name><name><surname>Lee</surname> <given-names>CH</given-names></name><name><surname>Wang</surname> <given-names>KH</given-names></name><name><surname>Michel</surname> <given-names>JC</given-names></name><name><surname>Claxton</surname> <given-names>DP</given-names></name><name><surname>Baconguis</surname> <given-names>I</given-names></name><name><surname>Althoff</surname> <given-names>T</given-names></name><name><surname>Fischer</surname> <given-names>S</given-names></name><name><surname>Garcia</surname> <given-names>KC</given-names></name><name><surname>Gouaux</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Screening and large-scale expression of membrane proteins in mammalian cells for structural studies</article-title><source>Nature Protocols</source><volume>9</volume><fpage>2574</fpage><lpage>2585</lpage><pub-id pub-id-type="doi">10.1038/nprot.2014.173</pub-id><pub-id pub-id-type="pmid">25299155</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guse</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Calcium mobilizing second messengers derived from NAD</article-title><source>Biochimica Et Biophysica Acta (BBA) - Proteins and Proteomics</source><volume>1854</volume><fpage>1132</fpage><lpage>1137</lpage><pub-id pub-id-type="doi">10.1016/j.bbapap.2014.12.015</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haley</surname> <given-names>E</given-names></name><name><surname>Choi</surname> <given-names>W</given-names></name><name><surname>Fan</surname> <given-names>C</given-names></name><name><surname>Sun</surname> <given-names>W</given-names></name><name><surname>Du</surname> <given-names>J</given-names></name><name><surname>Lu</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Expression and purification of the human Lipid-sensitive cation channel TRPC3 for structural determination by Single-particle Cryo-electron microscopy</article-title><source>Journal of Visualized Experiments</source><pub-id pub-id-type="doi">10.3791/58754</pub-id><pub-id pub-id-type="pmid">30663716</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname> <given-names>Y</given-names></name><name><surname>Wakamori</surname> <given-names>M</given-names></name><name><surname>Ishii</surname> <given-names>M</given-names></name><name><surname>Maeno</surname> <given-names>E</given-names></name><name><surname>Nishida</surname> <given-names>M</given-names></name><name><surname>Yoshida</surname> <given-names>T</given-names></name><name><surname>Yamada</surname> <given-names>H</given-names></name><name><surname>Shimizu</surname> <given-names>S</given-names></name><name><surname>Mori</surname> <given-names>E</given-names></name><name><surname>Kudoh</surname> <given-names>J</given-names></name><name><surname>Shimizu</surname> <given-names>N</given-names></name><name><surname>Kurose</surname> <given-names>H</given-names></name><name><surname>Okada</surname> <given-names>Y</given-names></name><name><surname>Imoto</surname> <given-names>K</given-names></name><name><surname>Mori</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death</article-title><source>Molecular Cell</source><volume>9</volume><fpage>163</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(01)00438-5</pub-id><pub-id pub-id-type="pmid">11804595</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hecquet</surname> <given-names>CM</given-names></name><name><surname>Zhang</surname> <given-names>M</given-names></name><name><surname>Mittal</surname> <given-names>M</given-names></name><name><surname>Vogel</surname> <given-names>SM</given-names></name><name><surname>Di</surname> <given-names>A</given-names></name><name><surname>Gao</surname> <given-names>X</given-names></name><name><surname>Bonini</surname> <given-names>MG</given-names></name><name><surname>Malik</surname> <given-names>AB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cooperative interaction of <italic>trp</italic> melastatin channel transient receptor potential (TRPM2) with its splice variant TRPM2 short variant is essential for endothelial cell apoptosis</article-title><source>Circulation Research</source><volume>114</volume><fpage>469</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.114.302414</pub-id><pub-id pub-id-type="pmid">24337049</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heymann</surname> <given-names>JB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Guidelines for using bsoft for high resolution reconstruction and validation of biomolecular structures from electron micrographs</article-title><source>Protein Science</source><volume>27</volume><fpage>159</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1002/pro.3293</pub-id><pub-id pub-id-type="pmid">28891250</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>Y</given-names></name><name><surname>Winkler</surname> <given-names>PA</given-names></name><name><surname>Sun</surname> <given-names>W</given-names></name><name><surname>Lu</surname> <given-names>W</given-names></name><name><surname>Du</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Architecture of the TRPM2 channel and its activation mechanism by ADP-ribose and calcium</article-title><source>Nature</source><volume>562</volume><fpage>145</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0558-4</pub-id><pub-id pub-id-type="pmid">30250252</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iordanov</surname> <given-names>I</given-names></name><name><surname>Mihályi</surname> <given-names>C</given-names></name><name><surname>Tóth</surname> <given-names>B</given-names></name><name><surname>Csanády</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The proposed channel-enzyme transient receptor potential melastatin 2 does not possess ADP ribose hydrolase activity</article-title><source>eLife</source><volume>5</volume><elocation-id>e17600</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.17600</pub-id><pub-id pub-id-type="pmid">27383051</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iordanov</surname> <given-names>I</given-names></name><name><surname>Tóth</surname> <given-names>B</given-names></name><name><surname>Szollosi</surname> <given-names>A</given-names></name><name><surname>Csanády</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Enzyme activity and selectivity filter stability of ancient TRPM2 channels were simultaneously lost in early vertebrates</article-title><source>eLife</source><volume>8</volume><elocation-id>e44556</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.44556</pub-id><pub-id pub-id-type="pmid">30938679</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname> <given-names>Y</given-names></name><name><surname>Lee</surname> <given-names>SH</given-names></name><name><surname>Lee</surname> <given-names>B</given-names></name><name><surname>Jung</surname> <given-names>S</given-names></name><name><surname>Khalid</surname> <given-names>A</given-names></name><name><surname>Uchida</surname> <given-names>K</given-names></name><name><surname>Tominaga</surname> <given-names>M</given-names></name><name><surname>Jeon</surname> <given-names>D</given-names></name><name><surname>Oh</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>TRPM2, a susceptibility gene for bipolar disorder, regulates glycogen synthase Kinase-3 activity in the brain</article-title><source>Journal of Neuroscience</source><volume>35</volume><fpage>11811</fpage><lpage>11823</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5251-14.2015</pub-id><pub-id pub-id-type="pmid">26311765</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname> <given-names>Y</given-names></name><name><surname>Lee</surname> <given-names>B</given-names></name><name><surname>Kim</surname> <given-names>H</given-names></name><name><surname>Jung</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>SH</given-names></name><name><surname>Lee</surname> <given-names>SY</given-names></name><name><surname>Jeon</surname> <given-names>JH</given-names></name><name><surname>Kim</surname> <given-names>IB</given-names></name><name><surname>Lee</surname> <given-names>SH</given-names></name><name><surname>Kim</surname> <given-names>BJ</given-names></name><name><surname>Kim</surname> <given-names>UH</given-names></name><name><surname>Lee</surname> <given-names>Y</given-names></name><name><surname>Kim</surname> <given-names>SM</given-names></name><name><surname>Jeon</surname> <given-names>D</given-names></name><name><surname>Oh</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Trpm2 ablation accelerates protein aggregation by impaired ADPR and autophagic clearance in the brain</article-title><source>Molecular Neurobiology</source><volume>56</volume><fpage>3819</fpage><lpage>3832</lpage><pub-id pub-id-type="doi">10.1007/s12035-018-1309-0</pub-id><pub-id pub-id-type="pmid">30215158</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kam</surname> <given-names>TI</given-names></name><name><surname>Mao</surname> <given-names>X</given-names></name><name><surname>Park</surname> <given-names>H</given-names></name><name><surname>Chou</surname> <given-names>SC</given-names></name><name><surname>Karuppagounder</surname> <given-names>SS</given-names></name><name><surname>Umanah</surname> <given-names>GE</given-names></name><name><surname>Yun</surname> <given-names>SP</given-names></name><name><surname>Brahmachari</surname> <given-names>S</given-names></name><name><surname>Panicker</surname> <given-names>N</given-names></name><name><surname>Chen</surname> <given-names>R</given-names></name><name><surname>Andrabi</surname> <given-names>SA</given-names></name><name><surname>Qi</surname> <given-names>C</given-names></name><name><surname>Poirier</surname> <given-names>GG</given-names></name><name><surname>Pletnikova</surname> <given-names>O</given-names></name><name><surname>Troncoso</surname> <given-names>JC</given-names></name><name><surname>Bekris</surname> <given-names>LM</given-names></name><name><surname>Leverenz</surname> <given-names>JB</given-names></name><name><surname>Pantelyat</surname> <given-names>A</given-names></name><name><surname>Ko</surname> <given-names>HS</given-names></name><name><surname>Rosenthal</surname> <given-names>LS</given-names></name><name><surname>Dawson</surname> <given-names>TM</given-names></name><name><surname>Dawson</surname> <given-names>VL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson's disease</article-title><source>Science</source><volume>362</volume><elocation-id>eaat8407</elocation-id><pub-id pub-id-type="doi">10.1126/science.aat8407</pub-id><pub-id pub-id-type="pmid">30385548</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashio</surname> <given-names>M</given-names></name><name><surname>Sokabe</surname> <given-names>T</given-names></name><name><surname>Shintaku</surname> <given-names>K</given-names></name><name><surname>Uematsu</surname> <given-names>T</given-names></name><name><surname>Fukuta</surname> <given-names>N</given-names></name><name><surname>Kobayashi</surname> <given-names>N</given-names></name><name><surname>Mori</surname> <given-names>Y</given-names></name><name><surname>Tominaga</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Redox signal-mediated sensitization of transient receptor potential melastatin 2 (TRPM2) to temperature affects macrophage functions</article-title><source>PNAS</source><volume>109</volume><fpage>6745</fpage><lpage>6750</lpage><pub-id pub-id-type="doi">10.1073/pnas.1114193109</pub-id><pub-id pub-id-type="pmid">22493272</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolisek</surname> <given-names>M</given-names></name><name><surname>Beck</surname> <given-names>A</given-names></name><name><surname>Fleig</surname> <given-names>A</given-names></name><name><surname>Penner</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cyclic ADP-ribose and hydrogen peroxide synergize with ADP-ribose in the activation of TRPM2 channels</article-title><source>Molecular Cell</source><volume>18</volume><fpage>61</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2005.02.033</pub-id><pub-id pub-id-type="pmid">15808509</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kühn</surname> <given-names>FJ</given-names></name><name><surname>Kühn</surname> <given-names>C</given-names></name><name><surname>Winking</surname> <given-names>M</given-names></name><name><surname>Hoffmann</surname> <given-names>DC</given-names></name><name><surname>Lückhoff</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>ADP-Ribose activates the TRPM2 channel from the sea Anemone nematostella vectensis independently of the NUDT9H domain</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0158060</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0158060</pub-id><pub-id pub-id-type="pmid">27333281</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kühn</surname> <given-names>FJP</given-names></name><name><surname>Watt</surname> <given-names>JM</given-names></name><name><surname>Potter</surname> <given-names>BVL</given-names></name><name><surname>Lückhoff</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Different substrate specificities of the two ADPR binding sites in TRPM2 channels of Nematostella vectensis and the role of IDPR</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>4985</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-41531-4</pub-id><pub-id pub-id-type="pmid">30899048</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kühn</surname> <given-names>FJ</given-names></name><name><surname>Lückhoff</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Sites of the NUDT9-H domain critical for ADP-ribose activation of the cation channel TRPM2</article-title><source>Journal of Biological Chemistry</source><volume>279</volume><fpage>46431</fpage><lpage>46437</lpage><pub-id pub-id-type="doi">10.1074/jbc.M407263200</pub-id><pub-id pub-id-type="pmid">15347676</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>Y</given-names></name><name><surname>Yu</surname> <given-names>X</given-names></name><name><surname>Ma</surname> <given-names>C</given-names></name><name><surname>Luo</surname> <given-names>J</given-names></name><name><surname>Yang</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Identification of a novel EF-Loop in the N-terminus of TRPM2 channel involved in calcium sensitivity</article-title><source>Frontiers in Pharmacology</source><volume>9</volume><elocation-id>581</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2018.00581</pub-id><pub-id pub-id-type="pmid">29915540</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansoor</surname> <given-names>SE</given-names></name><name><surname>Lu</surname> <given-names>W</given-names></name><name><surname>Oosterheert</surname> <given-names>W</given-names></name><name><surname>Shekhar</surname> <given-names>M</given-names></name><name><surname>Tajkhorshid</surname> <given-names>E</given-names></name><name><surname>Gouaux</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>X-ray structures define human P2X3 receptor gating cycle and antagonist action</article-title><source>Nature</source><volume>538</volume><fpage>66</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1038/nature19367</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mastronarde</surname> <given-names>DN</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Automated electron microscope tomography using robust prediction of specimen movements</article-title><source>Journal of Structural Biology</source><volume>152</volume><fpage>36</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2005.07.007</pub-id><pub-id pub-id-type="pmid">16182563</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McHugh</surname> <given-names>D</given-names></name><name><surname>Flemming</surname> <given-names>R</given-names></name><name><surname>Xu</surname> <given-names>S-Z</given-names></name><name><surname>Perraud</surname> <given-names>A-L</given-names></name><name><surname>Beech</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Critical Intracellular Ca <sup>2+</sup> Dependence of Transient Receptor Potential Melastatin 2 (TRPM2) Cation Channel Activation</article-title><source>Journal of Biological Chemistry</source><volume>278</volume><fpage>11002</fpage><lpage>11006</lpage><pub-id pub-id-type="doi">10.1074/jbc.M210810200</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mei</surname> <given-names>ZZ</given-names></name><name><surname>Mao</surname> <given-names>HJ</given-names></name><name><surname>Jiang</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Conserved cysteine residues in the pore region are obligatory for human TRPM2 channel function</article-title><source>American Journal of Physiology-Cell Physiology</source><volume>291</volume><fpage>C1022</fpage><lpage>C1028</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00606.2005</pub-id><pub-id pub-id-type="pmid">16822940</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittal</surname> <given-names>M</given-names></name><name><surname>Urao</surname> <given-names>N</given-names></name><name><surname>Hecquet</surname> <given-names>CM</given-names></name><name><surname>Zhang</surname> <given-names>M</given-names></name><name><surname>Sudhahar</surname> <given-names>V</given-names></name><name><surname>Gao</surname> <given-names>XP</given-names></name><name><surname>Komarova</surname> <given-names>Y</given-names></name><name><surname>Ushio-Fukai</surname> <given-names>M</given-names></name><name><surname>Malik</surname> <given-names>AB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Novel role of reactive oxygen species-activated <italic>trp</italic> melastatin channel-2 in mediating angiogenesis and postischemic neovascularization</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>35</volume><fpage>877</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.114.304802</pub-id><pub-id pub-id-type="pmid">25675998</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittal</surname> <given-names>M</given-names></name><name><surname>Nepal</surname> <given-names>S</given-names></name><name><surname>Tsukasaki</surname> <given-names>Y</given-names></name><name><surname>Hecquet</surname> <given-names>CM</given-names></name><name><surname>Soni</surname> <given-names>D</given-names></name><name><surname>Rehman</surname> <given-names>J</given-names></name><name><surname>Tiruppathi</surname> <given-names>C</given-names></name><name><surname>Malik</surname> <given-names>AB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Neutrophil activation of endothelial Cell-Expressed TRPM2 mediates transendothelial neutrophil migration and vascular injury</article-title><source>Circulation Research</source><volume>121</volume><fpage>1081</fpage><lpage>1091</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.311747</pub-id><pub-id pub-id-type="pmid">28790198</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreau</surname> <given-names>C</given-names></name><name><surname>Kirchberger</surname> <given-names>T</given-names></name><name><surname>Swarbrick</surname> <given-names>JM</given-names></name><name><surname>Bartlett</surname> <given-names>SJ</given-names></name><name><surname>Fliegert</surname> <given-names>R</given-names></name><name><surname>Yorgan</surname> <given-names>T</given-names></name><name><surname>Bauche</surname> <given-names>A</given-names></name><name><surname>Harneit</surname> <given-names>A</given-names></name><name><surname>Guse</surname> <given-names>AH</given-names></name><name><surname>Potter</surname> <given-names>BV</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Structure-activity relationship of adenosine 5'-diphosphoribose at the transient receptor potential melastatin 2 (TRPM2) channel: rational design of antagonists</article-title><source>Journal of Medicinal Chemistry</source><volume>56</volume><fpage>10079</fpage><lpage>10102</lpage><pub-id pub-id-type="doi">10.1021/jm401497a</pub-id><pub-id pub-id-type="pmid">24304219</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam Tran</surname> <given-names>H</given-names></name><name><surname>Hederih</surname> <given-names>J</given-names></name><name><surname>Numata</surname> <given-names>T</given-names></name><name><surname>Mori</surname> <given-names>MX</given-names></name><name><surname>Maegawa</surname> <given-names>S</given-names></name><name><surname>Hosokawa</surname> <given-names>H</given-names></name><name><surname>Mori</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Functional charaterization of zebrafish transient receptor potential melastatin 2</article-title><source>Biophysical Journal</source><volume>114</volume><fpage>641a</fpage><lpage>642a</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2017.11.3463</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikiforov</surname> <given-names>A</given-names></name><name><surname>Kulikova</surname> <given-names>V</given-names></name><name><surname>Ziegler</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The human NAD metabolome: functions, metabolism and compartmentalization</article-title><source>Critical Reviews in Biochemistry and Molecular Biology</source><volume>50</volume><fpage>284</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.3109/10409238.2015.1028612</pub-id><pub-id pub-id-type="pmid">25837229</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perraud</surname> <given-names>A-L</given-names></name><name><surname>Fleig</surname> <given-names>A</given-names></name><name><surname>Dunn</surname> <given-names>CA</given-names></name><name><surname>Bagley</surname> <given-names>LA</given-names></name><name><surname>Launay</surname> <given-names>P</given-names></name><name><surname>Schmitz</surname> <given-names>C</given-names></name><name><surname>Stokes</surname> <given-names>AJ</given-names></name><name><surname>Zhu</surname> <given-names>Q</given-names></name><name><surname>Bessman</surname> <given-names>MJ</given-names></name><name><surname>Penner</surname> <given-names>R</given-names></name><name><surname>Kinet</surname> <given-names>J-P</given-names></name><name><surname>Scharenberg</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by nudix motif homology</article-title><source>Nature</source><volume>411</volume><fpage>595</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1038/35079100</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname> <given-names>EF</given-names></name><name><surname>Goddard</surname> <given-names>TD</given-names></name><name><surname>Huang</surname> <given-names>CC</given-names></name><name><surname>Couch</surname> <given-names>GS</given-names></name><name><surname>Greenblatt</surname> <given-names>DM</given-names></name><name><surname>Meng</surname> <given-names>EC</given-names></name><name><surname>Ferrin</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>UCSF chimera--a visualization system for exploratory research and analysis</article-title><source>Journal of Computational Chemistry</source><volume>25</volume><fpage>1605</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1002/jcc.20084</pub-id><pub-id pub-id-type="pmid">15264254</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Punjani</surname> <given-names>A</given-names></name><name><surname>Rubinstein</surname> <given-names>JL</given-names></name><name><surname>Fleet</surname> <given-names>DJ</given-names></name><name><surname>Brubaker</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination</article-title><source>Nature Methods</source><volume>14</volume><fpage>290</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4169</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rack</surname> <given-names>JGM</given-names></name><name><surname>Ariza</surname> <given-names>A</given-names></name><name><surname>Drown</surname> <given-names>BS</given-names></name><name><surname>Henfrey</surname> <given-names>C</given-names></name><name><surname>Bartlett</surname> <given-names>E</given-names></name><name><surname>Shirai</surname> <given-names>T</given-names></name><name><surname>Hergenrother</surname> <given-names>PJ</given-names></name><name><surname>Ahel</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>(ADP-ribosyl)hydrolases: structural basis for differential substrate recognition and inhibition</article-title><source>Cell Chemical Biology</source><volume>25</volume><fpage>1533</fpage><lpage>1546</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2018.11.001</pub-id><pub-id pub-id-type="pmid">30472116</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheres</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>RELION: implementation of a bayesian approach to cryo-EM structure determination</article-title><source>Journal of Structural Biology</source><volume>180</volume><fpage>519</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2012.09.006</pub-id><pub-id pub-id-type="pmid">23000701</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname> <given-names>BW</given-names></name><name><surname>Perraud</surname> <given-names>AL</given-names></name><name><surname>Scharenberg</surname> <given-names>A</given-names></name><name><surname>Stoddard</surname> <given-names>BL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The crystal structure and mutational analysis of human NUDT9</article-title><source>Journal of Molecular Biology</source><volume>332</volume><fpage>385</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1016/S0022-2836(03)00954-9</pub-id><pub-id pub-id-type="pmid">12948489</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sievers</surname> <given-names>F</given-names></name><name><surname>Wilm</surname> <given-names>A</given-names></name><name><surname>Dineen</surname> <given-names>D</given-names></name><name><surname>Gibson</surname> <given-names>TJ</given-names></name><name><surname>Karplus</surname> <given-names>K</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Lopez</surname> <given-names>R</given-names></name><name><surname>McWilliam</surname> <given-names>H</given-names></name><name><surname>Remmert</surname> <given-names>M</given-names></name><name><surname>Söding</surname> <given-names>J</given-names></name><name><surname>Thompson</surname> <given-names>JD</given-names></name><name><surname>Higgins</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Fast, scalable generation of high-quality protein multiple sequence alignments using clustal omega</article-title><source>Molecular Systems Biology</source><volume>7</volume><elocation-id>539</elocation-id><pub-id pub-id-type="doi">10.1038/msb.2011.75</pub-id><pub-id pub-id-type="pmid">21988835</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sita</surname> <given-names>G</given-names></name><name><surname>Hrelia</surname> <given-names>P</given-names></name><name><surname>Graziosi</surname> <given-names>A</given-names></name><name><surname>Ravegnini</surname> <given-names>G</given-names></name><name><surname>Morroni</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>TRPM2 in the brain: role in health and disease</article-title><source>Cells</source><volume>7</volume><elocation-id>82</elocation-id><pub-id pub-id-type="doi">10.3390/cells7070082</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>K</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Kamm</surname> <given-names>GB</given-names></name><name><surname>Pohle</surname> <given-names>J</given-names></name><name><surname>Reis</surname> <given-names>FC</given-names></name><name><surname>Heppenstall</surname> <given-names>P</given-names></name><name><surname>Wende</surname> <given-names>H</given-names></name><name><surname>Siemens</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The TRPM2 channel is a hypothalamic heat sensor that limits fever and can drive hypothermia</article-title><source>Science</source><volume>353</volume><fpage>1393</fpage><lpage>1398</lpage><pub-id pub-id-type="doi">10.1126/science.aaf7537</pub-id><pub-id pub-id-type="pmid">27562954</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starkus</surname> <given-names>J</given-names></name><name><surname>Beck</surname> <given-names>A</given-names></name><name><surname>Fleig</surname> <given-names>A</given-names></name><name><surname>Penner</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Regulation of TRPM2 by extra- and intracellular calcium</article-title><source>The Journal of General Physiology</source><volume>130</volume><fpage>427</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1085/jgp.200709836</pub-id><pub-id pub-id-type="pmid">17893195</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumoza-Toledo</surname> <given-names>A</given-names></name><name><surname>Penner</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>TRPM2: a multifunctional ion channel for calcium signalling</article-title><source>The Journal of Physiology</source><volume>589</volume><fpage>1515</fpage><lpage>1525</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2010.201855</pub-id><pub-id pub-id-type="pmid">21135052</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>CH</given-names></name><name><surname>McNaughton</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The TRPM2 ion channel is required for sensitivity to warmth</article-title><source>Nature</source><volume>536</volume><fpage>460</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1038/nature19074</pub-id><pub-id pub-id-type="pmid">27533035</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Togashi</surname> <given-names>K</given-names></name><name><surname>Hara</surname> <given-names>Y</given-names></name><name><surname>Tominaga</surname> <given-names>T</given-names></name><name><surname>Higashi</surname> <given-names>T</given-names></name><name><surname>Konishi</surname> <given-names>Y</given-names></name><name><surname>Mori</surname> <given-names>Y</given-names></name><name><surname>Tominaga</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>TRPM2 activation by cyclic ADP-ribose at body temperature is involved in insulin secretion</article-title><source>The EMBO Journal</source><volume>25</volume><fpage>1804</fpage><lpage>1815</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601083</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tóth</surname> <given-names>B</given-names></name><name><surname>Iordanov</surname> <given-names>I</given-names></name><name><surname>Csanády</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Putative chanzyme activity of TRPM2 cation channel is unrelated to pore gating</article-title><source>PNAS</source><volume>111</volume><fpage>16949</fpage><lpage>16954</lpage><pub-id pub-id-type="doi">10.1073/pnas.1412449111</pub-id><pub-id pub-id-type="pmid">25385633</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tóth</surname> <given-names>B</given-names></name><name><surname>Csanády</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Identification of direct and indirect effectors of the transient receptor potential melastatin 2 (TRPM2) cation channel</article-title><source>Journal of Biological Chemistry</source><volume>285</volume><fpage>30091</fpage><lpage>30102</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.066464</pub-id><pub-id pub-id-type="pmid">20650899</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchida</surname> <given-names>K</given-names></name><name><surname>Dezaki</surname> <given-names>K</given-names></name><name><surname>Damdindorj</surname> <given-names>B</given-names></name><name><surname>Inada</surname> <given-names>H</given-names></name><name><surname>Shiuchi</surname> <given-names>T</given-names></name><name><surname>Mori</surname> <given-names>Y</given-names></name><name><surname>Yada</surname> <given-names>T</given-names></name><name><surname>Minokoshi</surname> <given-names>Y</given-names></name><name><surname>Tominaga</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Lack of TRPM2 impaired insulin secretion and glucose metabolisms in mice</article-title><source>Diabetes</source><volume>60</volume><fpage>119</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.2337/db10-0276</pub-id><pub-id pub-id-type="pmid">20921208</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchida</surname> <given-names>K</given-names></name><name><surname>Tominaga</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The role of TRPM2 in pancreatic β-cells and the development of diabetes</article-title><source>Cell Calcium</source><volume>56</volume><fpage>332</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.ceca.2014.07.001</pub-id><pub-id pub-id-type="pmid">25084624</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Fu</surname> <given-names>TM</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Xia</surname> <given-names>S</given-names></name><name><surname>Greka</surname> <given-names>A</given-names></name><name><surname>Wu</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structures and gating mechanism of human TRPM2</article-title><source>Science</source><volume>362</volume><elocation-id>eaav4809</elocation-id><pub-id pub-id-type="doi">10.1126/science.aav4809</pub-id><pub-id pub-id-type="pmid">30467180</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wehage</surname> <given-names>E</given-names></name><name><surname>Eisfeld</surname> <given-names>J</given-names></name><name><surname>Heiner</surname> <given-names>I</given-names></name><name><surname>Jüngling</surname> <given-names>E</given-names></name><name><surname>Zitt</surname> <given-names>C</given-names></name><name><surname>Lückhoff</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Activation of the cation channel long transient receptor potential channel 2 (LTRPC2) by hydrogen peroxide. A splice variant reveals a mode of activation independent of ADP-ribose</article-title><source>The Journal of Biological Chemistry</source><volume>277</volume><fpage>23150</fpage><lpage>23156</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112096200</pub-id><pub-id pub-id-type="pmid">11960981</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname> <given-names>CJ</given-names></name><name><surname>Headd</surname> <given-names>JJ</given-names></name><name><surname>Moriarty</surname> <given-names>NW</given-names></name><name><surname>Prisant</surname> <given-names>MG</given-names></name><name><surname>Videau</surname> <given-names>LL</given-names></name><name><surname>Deis</surname> <given-names>LN</given-names></name><name><surname>Verma</surname> <given-names>V</given-names></name><name><surname>Keedy</surname> <given-names>DA</given-names></name><name><surname>Hintze</surname> <given-names>BJ</given-names></name><name><surname>Chen</surname> <given-names>VB</given-names></name><name><surname>Jain</surname> <given-names>S</given-names></name><name><surname>Lewis</surname> <given-names>SM</given-names></name><name><surname>Arendall</surname> <given-names>WB</given-names></name><name><surname>Snoeyink</surname> <given-names>J</given-names></name><name><surname>Adams</surname> <given-names>PD</given-names></name><name><surname>Lovell</surname> <given-names>SC</given-names></name><name><surname>Richardson</surname> <given-names>JS</given-names></name><name><surname>Richardson</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>MolProbity: more and better reference data for improved all-atom structure validation</article-title><source>Protein Science</source><volume>27</volume><fpage>293</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1002/pro.3330</pub-id><pub-id pub-id-type="pmid">29067766</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname> <given-names>S</given-names></name><name><surname>Tanimoto</surname> <given-names>A</given-names></name><name><surname>Iwasa</surname> <given-names>S</given-names></name><name><surname>Otsuguro</surname> <given-names>K-ichi</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TRPM4 and TRPM5 channels share crucial amino acid residues for Ca2+ sensitivity but not significance of PI(4,5)P2</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><elocation-id>2012</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20082012</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname> <given-names>Y</given-names></name><name><surname>Wu</surname> <given-names>M</given-names></name><name><surname>Zubcevic</surname> <given-names>L</given-names></name><name><surname>Borschel</surname> <given-names>WF</given-names></name><name><surname>Lander</surname> <given-names>GC</given-names></name><name><surname>Lee</surname> <given-names>SY</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structure of the cold- and menthol-sensing ion channel TRPM8</article-title><source>Science</source><volume>359</volume><fpage>237</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1126/science.aan4325</pub-id><pub-id pub-id-type="pmid">29217583</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname> <given-names>Y</given-names></name><name><surname>Le</surname> <given-names>SC</given-names></name><name><surname>Hsu</surname> <given-names>AL</given-names></name><name><surname>Borgnia</surname> <given-names>MJ</given-names></name><name><surname>Yang</surname> <given-names>H</given-names></name><name><surname>Lee</surname> <given-names>SY</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>Structural basis of cooling agent and lipid sensing by the cold-activated TRPM8 channel</article-title><source>Science</source><volume>363</volume><elocation-id>eaav9334</elocation-id><pub-id pub-id-type="doi">10.1126/science.aav9334</pub-id><pub-id pub-id-type="pmid">30733385</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Yin</surname> <given-names>Y</given-names></name><name><surname>Wu</surname> <given-names>M</given-names></name><name><surname>Hsu</surname> <given-names>AL</given-names></name><name><surname>Borschel</surname> <given-names>WF</given-names></name><name><surname>Borgnia</surname> <given-names>MJ</given-names></name><name><surname>Lander</surname> <given-names>GC</given-names></name><name><surname>Lee</surname> <given-names>S-Y</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>Visualizing structural transitions of ligand-dependent gating of the TRPM2 channel</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/516468</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>P</given-names></name><name><surname>Xue</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Hu</surname> <given-names>X</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Jiang</surname> <given-names>LH</given-names></name><name><surname>Jin</surname> <given-names>H</given-names></name><name><surname>Luo</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Yang</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Identification of the ADPR binding pocket in the NUDT9 homology domain of TRPM2</article-title><source>The Journal of General Physiology</source><volume>149</volume><fpage>219</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1085/jgp.201611675</pub-id><pub-id pub-id-type="pmid">28108595</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>P</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Yu</surname> <given-names>X</given-names></name><name><surname>Ye</surname> <given-names>P</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Xue</surname> <given-names>X</given-names></name><name><surname>Yang</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Fang</surname> <given-names>C</given-names></name><name><surname>Zhao</surname> <given-names>YJ</given-names></name><name><surname>Yang</surname> <given-names>F</given-names></name><name><surname>Luo</surname> <given-names>JH</given-names></name><name><surname>Jiang</surname> <given-names>LH</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Yang</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Direct gating of the TRPM2 channel by cADPR via specific interactions with the ADPR binding pocket</article-title><source>Cell Reports</source><volume>27</volume><fpage>3684</fpage><lpage>3695</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.05.067</pub-id><pub-id pub-id-type="pmid">31216484</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Jung</surname> <given-names>DY</given-names></name><name><surname>Ko</surname> <given-names>HJ</given-names></name><name><surname>Lee</surname> <given-names>Y</given-names></name><name><surname>Friedline</surname> <given-names>RH</given-names></name><name><surname>Lee</surname> <given-names>E</given-names></name><name><surname>Jun</surname> <given-names>J</given-names></name><name><surname>Ma</surname> <given-names>Z</given-names></name><name><surname>Kim</surname> <given-names>F</given-names></name><name><surname>Tsitsilianos</surname> <given-names>N</given-names></name><name><surname>Chapman</surname> <given-names>K</given-names></name><name><surname>Morrison</surname> <given-names>A</given-names></name><name><surname>Cooper</surname> <given-names>MP</given-names></name><name><surname>Miller</surname> <given-names>BA</given-names></name><name><surname>Kim</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>TRPM2 Ca2<sup>+</sup> channel regulates energy balance and glucose metabolism</article-title><source>American Journal of Physiology. Endocrinology and Metabolism</source><volume>302</volume><fpage>E807</fpage><lpage>E816</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00239.2011</pub-id><pub-id pub-id-type="pmid">22275755</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Gctf: real-time CTF determination and correction</article-title><source>Journal of Structural Biology</source><volume>193</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2015.11.003</pub-id><pub-id pub-id-type="pmid">26592709</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Tóth</surname> <given-names>B</given-names></name><name><surname>Szollosi</surname> <given-names>A</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Csanády</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structure of a TRPM2 channel in complex with Ca<sup>2+</sup> explains unique gating regulation</article-title><source>eLife</source><volume>7</volume><elocation-id>e36409</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.36409</pub-id><pub-id pub-id-type="pmid">29745897</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>SQ</given-names></name><name><surname>Palovcak</surname> <given-names>E</given-names></name><name><surname>Armache</surname> <given-names>JP</given-names></name><name><surname>Verba</surname> <given-names>KA</given-names></name><name><surname>Cheng</surname> <given-names>Y</given-names></name><name><surname>Agard</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy</article-title><source>Nature Methods</source><volume>14</volume><fpage>331</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4193</pub-id><pub-id pub-id-type="pmid">28250466</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.50175.028</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Islas</surname><given-names>Leon D</given-names></name><role>Reviewing Editor</role><aff><institution>Universidad Nacional Autónoma de México</institution><country>Mexico</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Islas</surname><given-names>Leon D</given-names></name><role>Reviewer</role><aff><institution>Universidad Nacional Autónoma de México</institution><country>Mexico</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Ligand recognition and gating mechanism through three ligand-binding sites of human TRPM2 channel&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, including Leon D Islas as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Olga Boudker as the Senior Editor.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>The reviewers find that the present manuscript contains great quality data and that it is an important contribution. However they also find that in its present form, some of the conclusions are not supported by the presentation and that some results are over interpreted an overhyped. The authors use phrases like: &quot;unprecedented and extremely complicated&quot;, which should be avoided. A more balanced presentation is required as well as attention to the main points below.</p><p>Essential revisions:</p><p>1) The reviewers find that the main conclusions about the roles of the two ADPR sites are not well substantiated. In particular no experiments regarding the open probabilities reached in the presence of one or two binding sites is presented. Also, the main conclusion of the paper that the ADPR1 site (MHR1/2) is the main site and the ADPR2 site (NUDH9H) is the secondary site stems from the fact that the inhibitor 8-Br-cADPR binds to the ADPR1 site, not the ADPR2 site. The authors indicate that 8-Br-cADPR acts as a competitive inhibitor. However, the authors failed to note that the Penner group showed that 8-Br-cADPR only inhibits cADPR, not ADPR (Kolisek, 2005). On the contrary, the Penner group found that co-application of ADPR and 8-Br-cADPR appeared to enhance the response of ADPR to some degree. Furthermore, cADPR is a very weak partial agonist, as its potency and efficacy are significantly lower than those of ADPR (&gt; 50-fold). Therefore, the authors need to perform the similar experiment of co-application of 8-Br-cADPR and ADPR to see if there is any dose-dependent inhibition of 8-Br-cADPR. The authors need to do a better job of siting previous literature, especially functional studies, within context.</p><p>2) At the end of the first paragraph of the subsection “Channel activation and inhibition”, assignment of the state of the ADPR-bound structure as partially-activated state is inappropriate, as the pore is closed. &quot;Partially activated&quot; implies that it is partially open so that ion can permeate through the channel. &quot;Pre-open state&quot; is more appropriate for the ADPR-bound structure.</p><p>3) In the second paragraph of the subsection “Channel activation and inhibition”, assignment of the ADPR/Ca<sup>2+</sup> bound structure as a pre-open state might be fine, but the authors' reasoning that &quot;because ADPR-bound state is partially activated the ADPR/Ca<sup>2+</sup> structure is pre-open&quot; is not appropriate.</p><p>4) The authors reveal a second ADPR binding site in the NUDT9-H domain of hsTRPM2. In contrast, ADPR binding was not observed in the NUDT9-H domain of the ADPR/Ca<sup>2+</sup>-drTRPM2 structure in their previous study. Does the local conformation of the NUDT9-H in drTRPM2 differ from the corresponding ADPR2 site in the ADPR/Ca<sup>2+</sup>-hsTRPM2 structure? How would structural comparisons suggest the differential binding of ADPR in the NUDT9-H domain between the two species? In general, an in depth comparison of the present structures with previous structures from other organisms is need in order to better present the different conformations seen in the <italic>H. sapiens</italic> structures.</p><p>5) The current cryo-EM density figures (Figure 1—figure supplement 3E-H) for the ligands are too small. Also, half-maps for all the ligands are not provided, including ADPR1, ADPR2, and 8-Br-cADPR. Cryo-EM density for these ligands as well as their half-maps should be shown in a separate supplementary figure.</p><p>6) For the model-map FSC figures (Figure 1—figure supplement 2), FSC curves calculated between each half-map and the model should be provided as well.</p><p>7) The authors perform 3d reconstructions with C4 symmetry imposed. Have authors performed asymmetric (C1) reconstruction to ensure that all the reconstructions assume strict C4 symmetry?</p><p>8) Regarding the electrophysiological experiments with the presumed binding site mutants, reduction of the ionic current magnitude is hard to interpret. Is the affinity being affected or is the allosteric transition (s) leading to opening? Is the reduction of current observed in some mutants due to a shift of the dose response or are the channels completely irresponsive to ADPR? A dose response or at least the response to more than one concentration of ADPR should be obtained in order to provide a less ambiguous interpretation of these data. If these data cannot be obtained in reasonable time, at least the conclusion that these residues directly affect binding should be toned down and other different possibilities for the effects should be discussed.</p><p>9) Authors should provide their cryo-EM maps as well as coordinates.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.50175.029</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The reviewers find that the main conclusions about the roles of the two ADPR sites are not well substantiated. In particular no experiments regarding the open probabilities reached in the presence of one or two binding sites is presented. Also, the main conclusion of the paper that the ADPR1 site (MHR1/2) is the main site and the ADPR2 site (NUDH9H) is the secondary site stems from the fact that the inhibitor 8-Br-cADPR binds to the ADPR1 site, not the ADPR2 site. The authors indicate that 8-Br-cADPR acts as a competitive inhibitor. However, the authors failed to note that the Penner group showed that 8-Br-cADPR only inhibits cADPR, not ADPR (Kolisek, 2005). On the contrary, the Penner group found that co-application of ADPR and 8-Br-cADPR appeared to enhance the response of ADPR to some degree. Furthermore, cADPR is a very weak partial agonist, as its potency and efficacy are significantly lower than those of ADPR (&gt; 50-fold). Therefore, the authors need to perform the similar experiment of co-application of 8-Br-cADPR and ADPR to see if there is any dose-dependent inhibition of 8-Br-cADPR. The authors need to do a better job of siting previous literature, especially functional studies, within context.</p></disp-quote><p>We thank the reviewers for this comment. We have now clarified in the Introduction and throughout the text that 8-Br-cADPR is an antagonist only for cADPR but not for ADPR and have cited the corresponding work from Penner’s group. We agree with reviewer that it is not conclusive to define the MHR1/2 as the primary site and the NUDT9-H as the secondary site. We have thus removed it from the text. Instead, we conclude that MHR1/2 represents an orthosteric binding site in TRPM2 across all species, which is explained in the fifth paragraph of the subsection “Ligand-binding sites”. It is worth noting that the Penner group found co-application of ADPR and 8-Br-cADPR did not always enhance the response of ADPR (Kolisek, 2005), on which there is currently no mechanistical understanding. In addition, we did not observe inhibition effect of 8-Br-cADPR for ADPR-evoked current either, in line with the findings by Penner’s group.</p><p>The open probability of wild type <italic>hs</italic>TRPM2 has been reported to be 0.67 in the presence of 100 µM ADPR and 1 µM free CalCl<sub>2</sub> in an inside-out configuration (Fliegert, Nat Chem Biol. 2017). Based on our electrophysiology experiments, both binding sites are indispensable for channel activation, and no current can be recorded if one of the two ADPR site is “knocked out” (Figure 3, 100 µM ADPR and 1 mM Ca<sup>2+</sup>, inside-out patch). We agree with the reviewer that the apparently abolished channel activation at the electrophysiology experiment condition in this manuscript may be caused by altered ligand affinity, or altered transition from ligand binding to channel opening, or a combination of both. We have thus revised the text accordingly (see the aforementioned paragraph). However, before a Po can be measured, it requires systematical examination whether the channel can still be activated in the presence of one ADPR site, which is out of the scope of the current study and is not required to support our suggestion that MHR1/2 represents an orthosteric binding site in TRPM2 across all species in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>2) At the end of the first paragraph of the subsection “Channel activation and inhibition”, assignment of the state of the ADPR-bound structure as partially-activated state is inappropriate, as the pore is closed. &quot;Partially activated&quot; implies that it is partially open so that ion can permeate through the channel. &quot;Pre-open state&quot; is more appropriate for the ADPR-bound structure.</p><p>3) In the second paragraph of the subsection “Channel activation and inhibition”, assignment of the ADPR/Ca<sup>2+</sup> bound structure as a pre-open state might be fine, but the authors' reasoning that &quot;because ADPR-bound state is partially activated the ADPR/Ca<sup>2+</sup> structure is pre-open&quot; is not appropriate.</p></disp-quote><p>We agree with the reviewers that it is not appropriate to assign the ADPR-bound structure as partially-activated state. Because both ADPR and Ca<sup>2+</sup> are absolutely required to activate the TRPM2, we believe it is appropriate to call it “ADPR-bound non-activated state”. We have also revised the reasoning according to the reviewers’ suggestion: “because the overall structure of ADPR/Ca<sup>2+</sup>-<italic>hs</italic>TRPM2 is nearly identical with the structure of non-activated ADPR-<italic>hs</italic>TRPM2.”</p><disp-quote content-type="editor-comment"><p>4) The authors reveal a second ADPR binding site in the NUDT9-H domain of hsTRPM2. In contrast, ADPR binding was not observed in the NUDT9-H domain of the ADPR/Ca<sup>2+</sup>-drTRPM2 structure in their previous study. Does the local conformation of the NUDT9-H in drTRPM2 differ from the corresponding ADPR2 site in the ADPR/Ca<sup>2+</sup>-hsTRPM2 structure? How would structural comparisons suggest the differential binding of ADPR in the NUDT9-H domain between the two species? In general, an in depth comparison of the present structures with previous structures from other organisms is need in order to better present the different conformations seen in the <italic>H. sapiens</italic> structures.</p></disp-quote><p>We fully agree with the reviewers that it would be insightful to compare structures of the same protein from different organisms. TRPM2 is a large and complex protein, and there are inherent local structural differences, e.g. secondary structures, between <italic>hs</italic>TRPM2 and <italic>dr</italic>TRPM2 which share a sequence similarity of less than 65%. Therefore, direct superimposing domain structures of the two species might not be sufficient to show the conformational differences which could be easily overwhelmed by the inherent structural differences between the two species. Nevertheless, the trends of motion induced by ligand binding are conserved for both proteins. Therefore, we believe it would be more meaningful to show these conformational changes along with measurements separately for each species. Several figures in this manuscript (Figure 2E, Figure 4A, Figure 5H-J, and Figure 1—figure supplement 5, Figure 4—figure supplement 1, Figure 5—figure supplement 1, Figure 6—figure supplement 1) are prepared in almost identical views to the ones in our <italic>dr</italic>TRPM2 paper (Huang, 2018), which nicely show the conserved motion upon ligand binding.</p><p>Unlike in <italic>hs</italic>TRPM2, the NUDT9-H domain in the <italic>dr</italic>TRPM2 structures are very flexible due to a lack of extensive interface with the rest of protein. Thus, we were only able to rigid-body fit a NUDT9-H homology model, which is generated using the crystal structure of human NUDT9, into the cryo-EM maps of EDTA-<italic>dr</italic>TRPM2 and ADPR/Ca<sup>2+</sup>-<italic>dr</italic>TRPM2. We were unable to reliably tell if there is difference between the NUDT9-H domain in EDTA-<italic>dr</italic>TRPM2 and ADPR/Ca<sup>2+</sup>-<italic>dr</italic>TRPM2, which has been clearly stated in our previous paper (Huang, 2018). Due to the same reason, we think it might be misleading to directly compare the structures of NUDT9-H of <italic>hs</italic>TRPM2 and <italic>dr</italic>TRPM2. Nevertheless, the rearrangement of the ligand-sensing layer upon binding of ADPR is conserved between two species, which is shown in Figure 4—figure supplement 1 of this manuscript and Figure 3 in Huang, 2018.</p><disp-quote content-type="editor-comment"><p>5) The current cryo-EM density figures (Figure 1—figure supplement 3E-H) for the ligands are too small. Also, half-maps for all the ligands are not provided, including ADPR1, ADPR2, and 8-Br-cADPR. Cryo-EM density for these ligands as well as their half-maps should be shown in a separate supplementary figure.</p></disp-quote><p>We have now included a new supplementary figure showing enlarged densities for ADPR1, ADPR2, 8-Br-cAPPR along with their half-maps (Figure 1—figure supplement 4).</p><disp-quote content-type="editor-comment"><p>6) For the model-map FSC figures (Figure 1—figure supplement 2), FSC curves calculated between each half-map and the model should be provided as well.</p></disp-quote><p>We have included model-map FSC curves between each half-map and model (Figure 1—figure supplement 2), which indicate no overfitting of the atomic models.</p><disp-quote content-type="editor-comment"><p>7) The authors perform 3d reconstructions with C4 symmetry imposed. Have authors performed asymmetric (C1) reconstruction to ensure that all the reconstructions assume strict C4 symmetry?</p></disp-quote><p>We have indeed performed C1 refinement prior to C4 refinement. The C1 maps are very similar to the C4 maps despite lower resolutions. We did not observe C2-symmeric features in the C1 maps as observed in the C2-symmetric <italic>dr</italic>TRPM2 (Yin et al., 2019).</p><disp-quote content-type="editor-comment"><p>8) Regarding the electrophysiological experiments with the presumed binding site mutants, reduction of the ionic current magnitude is hard to interpret. Is the affinity being affected or is the allosteric transition (s) leading to opening? Is the reduction of current observed in some mutants due to a shift of the dose response or are the channels completely irresponsive to ADPR? A dose response or at least the response to more than one concentration of ADPR should be obtained in order to provide a less ambiguous interpretation of these data. If these data cannot be obtained in reasonable time, at least the conclusion that these residues directly affect binding should be toned down and other different possibilities for the effects should be discussed.</p></disp-quote><p>We thank the reviewers for this comment that a reduction of current amplitude may be caused by different reasons. We have thus revised the text accordingly and added a discussion regarding possible reasons for the reduction of current.</p><p>“First, several mutants of the binding site in the MHR1/2 domain either markedly decreased or abolished channel activation in response to ADPR/Ca<sup>2+</sup>, which is caused by either altered affinity of ADPR to the MHR1/2 site, or altered allosteric transition from ligand binding to channel opening, or a combination of both (Figures 3A-C)”.</p><disp-quote content-type="editor-comment"><p>9) Authors should provide their cryo-EM maps as well as coordinates.</p></disp-quote><p>We have now provided the EMDB and PDB codes for the maps and coordinates in the section of Data Availability.</p></body></sub-article></article>